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ABSTRACT OF DISSERTATION

THE INFLUENCE OF CHOLESTEROL-RELATED MEMBRANE FLUIDITY ON
THE SHEAR STRESS CONTROL OF NEUTROPHIL ADHESION AND ITS
IMPLICATIONS IN HYPERCHOLESTEROLEMIA
Hypercholesterolemia is a significant risk factor in the development of
cardiovascular disease and is associated with chronic leukocyte adhesion in the
microvasculature. While the underlying mechanisms behind this have yet to be determined,
it may be possible that hypercholesterolemia impairs the fluid shear stress (FSS)
inactivation of neutrophils through the rigidifying effect of cholesterol on membrane
fluidity. FSS restricts surface expression of CD18 integrins through cathepsin B (ctsB)
proteolysis, which minimizes neutrophil adhesivity. If hypercholesterolemia blocks FSS
mechanotransduction, then the inhibition of CD18 cleavage may link pathologic blood
cholesterol elevations with dysregulated neutrophil adhesion. We hypothesized that
elevated cholesterol contributes to dysregulated neutrophil adhesion by impairing ctsB
FSS-induced CD18 cleavage through membrane fluidity changes.
In the first part of this study, we demonstrated that FSS-induced CD18 cleavage is
a robust response of neutrophils and involves selective cleavage of macrophage 1-antigen
(Mac1) through ctsB proteolysis. The second part of this study confirmed that ctsB
regulates neutrophil adhesion through its proteolytic actions on Mac1, an important
integrin involved in adhesion and chemotaxis. Specifically, ctsB accelerated neutrophil
motility through an effect on Mac1 integrins during pseudopod retraction. Furthermore, by
using a flow-based assay to quantify the mechanoregulation of neutrophil adhesivity, we
demonstrated that FSS-induced ctsB release promoted neutrophil detachment from
platelet-coated substrates and unstimulated endothelium. For the third part of this study,
we linked cholesterol-related membrane fluidity changes with the ability of FSS to restrict
neutrophil adhesion through Mac1. We also determined that pathologic cholesterol
elevations associated with hypercholesterolemia could block FSS-induced Mac1 cleavage
and were linked to disrupted tissue blood flow. This was accomplished using low-density
lipoprotein receptor deficient (LDLR-/-) mice fed a high-fat diet.
Ultimately, the results provided in the present study confirmed that cholesterolrelated changes in membrane fluidity blocked the ability of ctsB to regulate neutrophil
adhesion through FSS-induced Mac1 cleavage. This implicates an impaired neutrophil FSS
mechanotransduction response in the dysregulation of neutrophil adhesion associated with

hypercholesterolemia. Since dysregulated adhesion may be one of the earliest upstream
features of cardiovascular disease associated with hypercholesterolemia, the present study
provides a foundation for identifying a new mechanobiological factor in the pathobiology
of microcirculatory dysfunction.
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CHAPTER 1: INTRODUCTION
Cardiovascular disease is one of the leading causes of death for adults, with over
1.5 million cases each year in the United States [1]. By studying the upstream risk factors,
it may be possible to reduce the lethality of cardiovascular disease and prevent death.
Hypertension and hypercholesterolemia represent two diseases associated with
cardiovascular disease [2,3]. Patients with these conditions are likely to exhibit chronic
inflammation in the blood and microvascular dysfunction, two risk factors linked to the
development of lethal cardiovascular disease [4-6]. Historically, increased numbers of
activated leukocytes in the blood and microcirculation are associated with cardiovascular
disease [7-10], suggesting that dysregulated leukocyte activity may contribute toward
cardiovascular pathogenesis.
Neutrophils, the most numerous leukocyte subtype in the blood under physiological
conditions, are among the first responders of the acute inflammatory response [11]. These
cells are highly sensitive to stimuli, and can rapidly activate in the presence of as little as
10 – 100 bacterial peptides [12]. Due to this high sensitivity and their vast destructive
potential, it is possible that the neutrophils are highly susceptible to pathogenic factors and,
thus, serve as one of the earliest contributors to the onset of chronic inflammation. This
possibility is conceivable since tight regulation of neutrophil activity is essential to
maintain the body in a non-inflamed state. Failure to do so may result in sustained
neutrophil activation which contributes to lethal tissue injury [13] via an autodigestive
process, where dysregulated release of cytokines (which activate more inflammatory cells)
and biodegradative agents (e.g., reactive oxygen species, proteases, etc.) cause damage to
healthy vasculature [14]. Alternatively, sustained neutrophil activation in the blood may
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damage tissues indirectly by impacting blood rheology and impairing tissue perfusion [15].
Finally, progression of a chronic inflammatory state in the circulation could initiate from a
combination of both processes [16].
Although neutrophil inactivity is predicated on the absence of inflammatory
stimuli, several cellular and molecular mechanisms are in place to ensure that these cells
remain inactivated under physiologic conditions [17,18]. Recent evidence established fluid
shear stress (FSS) mechanotransduction as one potential regulatory mechanism [19].
Whether neutrophils are adherent or freely-floating, their activity is minimized by exposure
to FSS typical of the physiologic bloodstream, ensuring their circulation as rounded,
inactivated cells [20-22]. FSS inactivates neutrophils by minimizing pseudopod activity
and restricting their surface expression levels of CD18 integrins via a cleavage process
involving the release of lysosomal cysteine protease, cathepsin B (ctsB) [23]. These FSS
responses are thought to be important aspects of neutrophil regulation since their
impairment has been implicated as a potential contributor to pathological elevations in
peripheral vascular resistance [24,25].
To determine how neutrophil FSS mechanotransduction may become impaired and
contribute to microvascular pathogenesis, recent studies from our lab focused on the
cholesterol-related membrane fluidity of the cells [26,27]. This focus on cell membrane
fluidity was predicated on the principle that changing cell membrane mechanical properties
may alter the ability of FSSes to induce conformational (i.e., structural) activity in putative
mechanosensors on the neutrophil surface. Considering that cholesterol is an important
lipid regulator of the membrane fluidity of mammalian cells [28], changes in membrane
cholesterol content may conceivably alter cell sensitivity to physical stimuli.
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One scenario for which the cholesterol-related membrane properties may change
and lead to dysregulation of the neutrophils is hypercholesterolemia. Pathological blood
cholesterol elevations that occur during hypercholesterolemia are associated with chronic
leukocyte activation in the blood and microcirculation as well as microvascular dysfunction
[29]. By using pseudopod retraction to estimate FSS mechanosensitivity, cholesterolrelated changes in membrane fluidity were demonstrated to impair neutrophil
mechanotransduction and to be linked with the onset of microvascular dysfunction due to
hypercholesterolemia [26,27]. However, it remained to be determined how the impaired
neutrophil responsiveness to FSS, which was quantified by using pseudopod retraction as
a surrogate marker, manifested into microvascular dysfunction. The present study focused
on the possibility that an impaired ability of FSS to limit neutrophil CD18 surface
expression may explain the connection between hypercholesterolemia, dysregulated
neutrophil adhesion, and dysregulated microvascular function. For these purposes, the
present study tested the hypothesis that pathological blood cholesterol elevations
dysregulate neutrophil adhesion by reducing membrane fluidity and impairing FSSinduced ctsB release which blocks CD18 cleavage.
To address this hypothesis, the following specific aims were carried out:
1) Link ctsB release with reduced expression of neutrophil adhesion molecules.
2) Show that ctsB activity minimizes neutrophil adhesion under shear exposure.
3) Verify that neutrophil adhesion and detachment under flow is affected by
cholesterol-related changes in membrane fluidity.
4) Demonstrate that extracellular cholesterol elevations, similar to that of
hypercholesterolemia in vivo, block FSS regulation of neutrophil adhesion.
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CHAPTER 2: BACKGROUND
2.1 The Potential Impact of Neutrophil Activation on Blood Flow
As the most numerous leukocytes in the body, the neutrophils are second only to
the red blood cells (RBCs) in their impact on microvascular flow. Under physiologic
conditions, inactivated neutrophils patrol the circulation as spherical, non-adhesive cells.
This state enables their passive deformation through the microcirculation, ensuring that
they have a minimal impact on blood flow while inactivated [30]. Once activated, however,
neutrophils are capable of influencing blood rheology through changes to their cellular
geometry and adhesivity (Fig. 2.1).

Figure 2.1. The effects of neutrophil activation on microvascular blood flow.
Blood flow through non-capillary vessels can be impaired by neutrophil activation. Activated
neutrophils may project pseudopods which elevate the viscosity of blood. Alternatively,
activated neutrophils may adhere to the endothelium and reduce the apparent diameter of the
vessel. In both cases, resistance to flow is elevated due to the changes in viscosity or diameter.
In the case of the capillaries, activated neutrophils have been demonstrated to plug capillaries.
This restricts blood flow and elevates the resistance to flow.
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Neutrophils activate in response to stimulation with inflammatory agonists, such as
formyl-methionyl-leucyl-phenylalanine (fMLP) or platelet-activating factor (PAF) [15].
The most visible change that accompanies neutrophil activation is the extension of
pseudopods, causing the cell to adopt an irregular geometry [13]. In addition to projecting
pseudopods, neutrophils also upregulate their expression of CD18 cell-cell adhesion
molecules when stimulated with inflammatory agonists [31]. In these ways, neutrophil
activation may potentially impact blood rheology and flow within the microcirculation as
described in the following sections.

2.1.1 The rheological effects of activated neutrophils on microvascular flow
Activated neutrophils in the blood are capable of physically influencing
microvascular flow and thus affecting peripheral resistance. This influence may be roughly
inferred from the Hagen-Poiseuille approximation in the following forms:
Ω ∝ µ/Ac (microvessel network)
or

Ω ∝ µ/D4 (single vessels)

where Ω is microvessel resistance, µ is cell suspension viscosity, Ac is total cross-sectional
area to flow, and D is vessel diameter. This relationship exemplifies how changes in either
the blood apparent viscosity or the microvasculature geometry may affect flow resistance.
In microvascular networks, inactivated neutrophils with diameters of 12–15 μm are
capable of deforming and squeezing through capillaries with diameters of 5–10 μm [32,33].
However, activated neutrophils express F-actin enriched pseudopods and are far less
deformable, which may lead to capillary plugging (Fig. 2.1, Plugging Effect) [34]. A
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significant degree of capillary plugging in microvascular networks, which would manifest
as a reduction in the total cross-sectional area to flow of capillary beds, would lead to
increased peripheral resistance. Because the capillaries make up the greatest total cross
sectional area in the body [35], a significant degree of capillary plugging can have a great
effect on flow resistance.
Activated neutrophils may also have an effect on microvascular flow within the
non-capillary microcirculation. Presumably, the presence of pseudopod projections on
neutrophils causes them to adopt irregular, non-spherical shapes that increase their
tumbling behavior in the linear velocity gradient of the blood flow field within vessels.
This enhanced tumbling may increase the number of collisions they experience with other
cell types, including the numerous RBCs in the surrounding environment [36,37]. As
RBCs are displaced laterally toward the low viscosity cell-free plasma layer located near
the vessel wall [38], the apparent viscosity of the blood is elevated (Fig. 2.1, Viscous
Effect). According to the Hagen-Poiseuille approximation, this means flow resistance is
increased in response to activated neutrophils, due to pseudopod-induced elevations in the
apparent viscosity of blood in the non-capillary microvasculature (10 – 300 μm in diameter
[39]) which make up a large percentage of microvessels in the microcirculation. This
potential influence of cell activation and viscosity on flow resistance was supported by in
vivo evidence, where interactions between activated leukocytes and RBCs in blood-like
cell suspensions elevated both apparent viscosity and flow resistance [40].
It may also be possible for activated neutrophils to alter microvascular resistance
by adhering to the non-capillary microvasculature, particularly the venules. Upregulation
of CD18 integrins on activated neutrophils causes these cells to become much more

6

adhesive than their inactivated counterparts. Consequently, the apparent diameter of a
microvessel may decrease if significant numbers of rolling and migrating neutrophils are
present on the microvascular walls (Fig. 2.1, Geometric Effect). According to the HagenPoiseuille approximation, it may be possible that a reduction in apparent diameter would
elevate microvascular resistance, due to the inverse 4th power relationship between
resistance and diameter. In support of this, studies have shown that inflammatory
stimulation can promote leukocyte adhesion and migration in the capillaries and noncapillary microvessels, with an enhancing effect on microvascular resistance [41].

2.1.2 The effects of activated neutrophils on endothelial cell functions
It is important to note that the previously described mechanisms have focused on
the rheological effects of neutrophil activation alone. However, neutrophils may also affect
microvascular flow by biologically modifying the activity of other cells. For example, their
binding may influence the activity of endothelial cells responsible for regulating blood flow
through the release of signaling molecules (i.e., nitric oxide, prostacyclin, thromboxane,
endothelin) [42]. Endothelial signaling in response to changes in the intravascular
environment can lead to the dilation or constriction of vascular smooth muscle, altering the
microvascular resistance to blood flow [42,43]. Alternatively, signaling molecules can
change the permeability of the endothelium, leading to a net transfer in fluid from the
venules to the interstitial tissues which may alter interstitial pressures and physically
interfere with the function of neighboring arterioles [44,45].
It is difficult for circulating neutrophils to affect endothelial cell activity, due to the
extracellular fluid containing antioxidants and protease inhibitors which limit leukocyte
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cytotoxicity under physiologic conditions [46]. However, the recruitment/adhesion of
neutrophils to endothelial cells creates a sequestered “microenvironment” which enables
neutrophil oxidants and proteases to overwhelm these restrictive factors [47,48]. This
enables adhesive neutrophils to exert their full cytotoxic effects, which are capable of
altering the activity of endothelial cells [14,49]. Importantly, the secretion of endothelial
products and the permeability of endothelial cells may be altered by adhesive neutrophils
[50,51]. This suggests that sustained neutrophil adhesion to the microvascular wall may
lead to dysregulated endothelial cell activity in the microvasculature (Fig. 2.2). The
impaired secretion of endothelial productions responsible for vasomotor control, for
example, would affect microvascular flow resistance [52], leading to disrupted tissue blood
flow and microvascular dysfunction. Additionally, increased endothelial permeability may
have paracrine or systemic effects, where the surrounding cells are affected by cytokine
release [53,54]. These surrounding cells would then activate and secrete more cytokines,
promoting a chronic inflammatory state that sustains dysregulated neutrophil and
endothelial cell activity.
In summary, dysregulated neutrophil activity may disrupt tissue blood flow either
directly through a physical effect or indirectly through actions on endothelial cells of the
microvasculature. This possibility implicates the neutrophils as a critical feature of
microvascular blood flow rheology. It also suggests that dysregulation of the neutrophils
may contribute to microvascular dysfunction and downstream lethal pathologies due to
factors that affect their responsiveness to FSS (e.g., hypercholesterolemia).
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Figure 2.2. The proposed impact of neutrophil activation on hemodynamic resistance
and blood flow regulation in microvessels.
Flow resistance may be altered by the effects of activated neutrophils on endothelial cells.
This may manifest as either dysregulated cytokine release or increased tissue permeability,
both of which contribute to microvascular dysfunction. Ultimately, sustained neutrophil and
endothelial cell activation promote a chronic inflammatory state that can lead to lethal
cardiovascular disease. The impact of the neutrophils here is focused on blood flow in the
non-capillary vessels.

2.2 Control of Neutrophil Activity by Fluid Shear Stress Mechanotransduction
2.2.1 Fluid shear stress induces retraction of neutrophil pseudopod projections
A growing body of evidence points to the mechanotransduction of hemodynamic
FSS (i.e., 1 – 10 dyn/cm2) [41] as a potential control mechanism in the blood for the purpose
of restricting leukocyte activity under physiological conditions, when their recruitment is
not needed [19,21,23]. FSS-induced pseudopod retraction represents one of the most overt
evidence in support of the ability of fluid flow mechanotransduction to promote neutrophil
deactivation. Within 1 – 2 minutes of being exposed to FSS (1 – 2 dyn/cm2) using a
9

micropipette, neutrophils migrating on glass substrates retract F-actin enriched pseudopods
and adopt a rounded morphology [21]. It appears as though FSS exposure interferes with
the ability of neutrophils to project pseudopods, since the F-actin content of neutrophils
will rapidly decrease in parallel with their pseudopod retraction response [55]. FSS has
also been demonstrated to reduce the phagocytic behavior of neutrophils, which relies on
the formation of pseudopods [56]. These observations support the ability of shear to
mechanobiologically restrict or limit pseudopod activity.

2.2.2 Fluid shear stress induces cleavage of CD18 by cathepsin B release
FSS downregulates the expression of intact CD18 adhesion molecules that mediate
firm adhesive interactions with substrates [23]. CD18 is the common β2 polypeptide
subunit for a family of heterodimeric integrins [57]. Of the four CD18 subtypes, the two
most numerous on the neutrophil surface are lymphocyte function-associated antigen 1
(LFA1; CD11a/CD18) and macrophage-1 antigen (Mac1; CD11b/CD18). LFA1 is
typically associated with loose capture interactions which promote neutrophil arrest during
inflammatory recruitment, and Mac1 supports the firm adherence of neutrophils to venular
walls, either directly on endothelium or via platelet bridges [58].
Reportedly, FSS-induced downregulation of CD18 expression involves proteolytic
cleavage of excess amounts of these integrins off the neutrophil surface. During in vitro
studies after harvest from fresh blood, reintroducing neutrophils to venular-level shear
stress (1.5 – 5 dyn/cm2) for as short as 5 minutes cleaves approximately 20 – 30% of cell
surface-associated CD18 integrins. This shedding process involves the FSS-induced
release of lysosomal cysteine protease ctsB at the cell surface [23]. Previous studies
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identified the role of ctsB through the use of broad-spectrum protease inhibitors. Blocking
the activity of several different protease families, such as serine or aspartyl proteases, did
not prevent the FSS-induced cleavage of CD18 integrins. However, blocking the activity
of cysteine proteases inhibited FSS-induced CD18 cleavage [23]. This inhibition was also
observed when ctsB activity was selectively blocked; however, selectively blocking other
cysteine proteases had no effect on FSS-induced CD18 cleavage.
Recently, our lab demonstrated that CD18 cleavage by neutrophils exposed to FSS
is specific for Mac1 and occurs in parallel with their reduced binding to platelets and
fibrinogen [59]. This suggested that Mac1 cleavage serves to reduce or prevent neutrophil
adhesion under flow. However, the underlying mechanism, including the protease
responsible for cleaving the CD11b subunits of Mac1, remained to be elucidated.
Furthermore, because Mac1 plays a role in firm adhesion, it remained to be demonstrated
whether ctsB-induced Mac1 cleavage restricted neutrophil binding to unstimulated
endothelium under flow.

2.2.3 Agonist stimulation overrides fluid shear stress mechanotransduction
Inactivation of neutrophils by FSS mechanotransduction occurs even in the
presence of low amounts of inflammatory agonists. Mild stimulation of neutrophils with <
1 µM fMLP or < 10 µM PAF does not compromise their ability to retract pseudopods when
exposed to FSS [19-21,27,60]. In contrast, stimulation of neutrophils with these same
agonists above their critical thresholds abolishes FSS-induced pseudopod retraction [20].
Intuitively, this dose-dependent relationship between agonist stimulation and impairment
of neutrophil deactivation under FSS makes sense. It is consistent with the likelihood that
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inflammatory agonists are capable of overriding the FSS-induced deactivation of
neutrophils, such as during acute inflammation when they are needed to respond to
infection or tissue injury.
Interestingly, deactivation of neutrophils under FSS exposure is linked with their
surface expression of G protein-coupled receptors (GPCRs) such as the formyl peptide
receptor (i.e., fMLP receptor) [61]. The desensitization of FPR by fMLP ligand binding is
typically associated with receptor internalization [62]. However FPR is reportedly
internalized into perinuclear compartments under shear exposure [63]. It has been
demonstrated that the shear-induced internalization of FPR causes neutrophils to resist
activation in response to low concentrations of fMLP [64]. This is in line with the
inactivation of neutrophils by FSS exposure in the presence of low quantities of
inflammatory agonists. Furthermore, it is possible that stimulation with agonists, such as
fMLP, above a threshold level, prevents FSS-induced GPCR internalization, and thus, the
neutrophils activate in spite of the local flow environment.
Overall, FSS mechanotransduction serves to maintain neutrophils in an inactivated
state. However, under some circumstances it is possible for neutrophils to become
unresponsive to FSS exposure. In the event that the FSS mechanotransduction response
becomes impaired, the dysregulation of neutrophil activity may have detrimental effects
on microvascular physiology.
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2.3 Consequences of Impaired Neutrophil Fluid Shear Stress Mechanotransduction
To date, there is an accumulation of evidence suggesting that, under physiologic
conditions, FSS serves to minimize the activity of neutrophils in the bloodstream unless
there is sufficient agonist stimulation to override this control mechanism. However, it is
also possible that FSS mechanotransduction becomes compromised due to the onset of
pathological conditions. Presumably, this impairment in the FSS mechanotransduction
response results in dysregulated neutrophil activation that eventually drives a chronic
inflammatory phenotype in the body.
Neutrophils promote an inflammatory phenotype by releasing cytokines and cell
agonists that not only promote tissue injury, but also recruit other leukocytes [65,66]. As a
result, the dysregulated activity (i.e., sustained activation) of neutrophils and other
leukocytes can damage host tissue and promote the development of chronic inflammation,
a common denominator for a wide variety of lethal pathologies (e.g., microvascular
dysfunction, cardiovascular disease, diabetes, cancer, etc.) [67,68]. Since neutrophils are
among the first leukocytes recruited during inflammation, their sustained activity due to
impairment of regulatory mechanisms may be one of the earliest upstream factors driving
the dysregulation of microvascular flow associated with chronic inflammation (Fig. 2.3).
In line with this, past studies have linked an impaired FSS mechanotransduction response
with dysregulated neutrophil activity and microvascular dysfunction.
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Figure 2.3. The potential impact of impaired neutrophil fluid shear stress
mechanotransduction on microvascular rheology.
The regulation of neutrophil activity under physiologic conditions, represented by the blue
arrows, ensures neutrophils remain quiescent under non-inflamed conditions. This is
accomplished, in part, due to the inactivation of neutrophils by FSS mechanotransduction.
Exposure to pro-inflammatory stimuli temporarily overrides the FSS mechanotransduction
response and activates neutrophils, leading to inflammation. When inflammation is resolved
and agonist levels subside, neutrophils become responsive to FSS mechanotransduction once
more and are inactivated. Impairment of FSS mechanotransduction by pathologic conditions,
represented by the red arrows, can lead to sustained neutrophil activation in the blood. This,
combined with the elevated expression of pro-inflammatory cytokines, promotes a chronic
inflammatory state. The accumulation of activated neutrophils during chronic inflammation is
thought to contribute to microvascular dysfunction.

Evidence that impaired neutrophil mechanosensitivity contributes to microvascular
dysfunction has been reported for rats exhibiting a chronically inflamed phenotype as a
result of spontaneous hypertension [24,25,69]. Spontaneously hypertensive rats (SHRs)
were found to have significantly elevated hemodynamic resistance due to the sustained
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levels of chronically activated neutrophils [25]. The neutrophils from SHRs were found to
be unresponsive to FSS exposure. Unlike wild type (WT) neutrophils which retracted
pseudopods in the presence of shear, SHR neutrophils lacked a functioning pseudopod
retraction response. The persistent presence of pseudopods on SHR neutrophils in the
bloodstream were reported to contribute to the elevations in microvascular resistance
associated with hypertension [70,71].
It should be noted that spherical leukocytes in the blood might increase apparent
viscosity and elevate microvascular flow resistance due to their interactions with RBCs in
the flow field [37,72]. This connection may be explained by the presence of pseudopod
projections on neutrophils, which enhance their tumbling and exacerbate their impact on
surrounding RBC motion, ultimately elevating both apparent viscosity and microvascular
resistance to a higher degree than if cellular projections were not present. Recently, we
reported that mixed suspensions of activated leukocytes and hematocrit elevate the flow
resistance of non-capillary microvascular mimics to a greater degree than similar
suspensions with inactivated leukocytes alone (Fig. A.1 and Fig. A.2, Appendix A) [73].
However, although pseudopod extensions had a significant effect on microvascular flow
resistance in vitro, the magnitude of these flow resistance elevations may not be
biologically relevant to induce pathology in vivo.
Further evidence regarding impaired neutrophil mechanosensitivity and its putative
involvement in microcirculatory pathogenesis came from previous studies from our lab
using a hypercholesterolemia murine model. Hypercholesterolemia induces a chronic
inflammatory phenotype within the microcirculation, which drives downstream
microvascular dysfunction. When neutrophils were taken from the hypercholesterolemic
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mice and exposed to shear, these cells were found to have impaired FSS
mechanosensitivity; specifically, they were deficient in their pseudopod retraction response
to shear exposure [27]. Furthermore, this impaired FSS pseudopod retraction response was
correlated with disrupted tissue blood flow autoregulation (i.e., microvascular dysfunction)
[26], implicating a link between dysregulated neutrophil activity and microvascular
dysfunction. Combined, these observations suggested that the pathologic cholesterol
elevations associated with hypercholesterolemia played a role in the impairment of
neutrophil FSS mechanosensitivity.

2.4 Hypercholesterolemia-Associated Dysregulation of Neutrophil Adhesion
2.4.1 Dysregulated neutrophil adhesion is a key feature of hypercholesterolemia
Hypercholesterolemia is associated with chronically inflamed blood typified by
elevations in the number of activated neutrophils in the microcirculation [74]. One of the
first features to manifest during hypercholesterolemia appears to be sustained neutrophil
adhesion in the blood and microcirculation. The formation of leukocyte-platelet
aggregates, for example, is reportedly enhanced in hypercholesterolemic mice [75].
Additionally, neutrophils also exhibit increased adhesivity to endothelium in
hypercholesterolemic rabbits [76]. This enhanced adhesion may be due to the increased
Mac1 expression reported for neutrophils subjected to a hypercholesterolemic environment
[77]. Sustained neutrophil adhesion, in turn, may drive endothelial cell dysfunction [74,78],
leading to tissue blood flow dysregulation and microvascular dysfunction.
Many factors potentially contribute to the reported dysregulation in neutrophil
adhesion during hypercholesterolemia. For example, superoxide production by neutrophils
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positively correlates with plasma cholesterol levels [79]. The enhanced production of
superoxide, in turn, reduces the bioavailability of nitric oxide (NO), a mediator of
neutrophil adhesion [80]. Notably, impaired NO production by endothelial cells supports
dysregulated neutrophil adhesion [81]. This means a combination of enhanced superoxide
production and reduced NO availability may promote dysregulated neutrophil adhesion
and sustain the chronic inflammatory phenotype observed during hypercholesterolemia.
Interestingly, reduced NO levels in the blood have been linked to an impaired neutrophil
FSS response [20], suggesting that neutrophil activity may become dysregulated. However,
NO production may also be limited independently of neutrophils due to endothelial cell
dysfunction [82], which further promotes adhesion and a chronic inflammatory phenotype.

2.4.2 Dysregulated neutrophils impair the post-occlusive reactive hyperemia response in
hypercholesterolemic mice
Once adhered, neutrophils may contribute to microvascular dysfunction by
dysregulating tissue blood flow. Conceivably, accumulation of chronically activated
neutrophils dysregulates microvascular blood flow and disrupts vascular perfusion, leading
to lethal tissue injury [83]. Research from our own lab involving neutrophil shear
regulation during tissue blood flow autoregulation in response to post-occlusive reactive
hyperemia (poRH) further supports this possibility [26].
The poRH response represents a transient overshoot in blood flow during recovery
of microvascular tissues in response to a brief period of blood stasis, which elicits ischemia
in downstream tissues [74,84]. PoRH is commonly used to assess the health state of
microvascular function (e.g., tissue blood flow autoregulation). After the initiation of
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reperfusion, the blood flow overshoot prior to its return to baseline is believed to occur due
to initial vasodilation of blood vessels, enabling the rapid transport of blood to oxygenstarved tissues [85]. Once blood flow has been restored and tissues are reoxygenated,
vasoconstriction reduces flow back to pre-stasis levels. While it is believed that endothelial
cell functions (e.g., NO release) are involved in regulating blood flow during poRH [84],
some studies suggest that factors outside the endothelial cells also play a role [86].
Our prior research focused on the contributions of neutrophils to the impaired poRH
response observed during hypercholesterolemia [26,27]. In particular, we found that an
impaired poRH response was positively correlated with an impaired pseudopod retraction
response to FSS (our surrogate index of shear sensitivity) and elevated cholesterol levels.
As such, an impaired FSS response may represent one of the earliest contributing factors
toward microvascular dysfunction associated with hypercholesterolemia by promoting
tissue blood flow dysregulation. However, the mitigating event linking dysregulated
neutrophil activity with hypercholesterolemia remained unclear.
One possible explanation for the impaired blood flow response to poRH observed
for hypercholesterolemic mice may be related to dysregulated neutrophil adhesion [74-76].
Neutrophils in a hypercholesterolemic environment exhibit an upregulated expression of
adhesion integrins [77]. This upregulated expression may be linked with an impaired FSS
mechanotransduction response. Similarly to FSS-induced pseudopod retraction, FSSinduced CD18 cleavage may also be impaired by pathological blood cholesterol elevations.
This impairment may be the central link, which connects hypercholesterolemia,
microvascular dysfunction, and dysregulated neutrophil adhesion. However, the
mechanistic basis for this dysregulation remains to be demonstrated.
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2.5 The Role of the Cell Membrane in Fluid Shear Stress Mechanosensitivity
Because blood borne cells, including the neutrophils, are likely to experience
large fluctuations in shear stress levels as they circulate through the body [41,87],
atypical shear distributions alone are more than likely not the cause of cellular
dysfunction. Instead, it is conceivable that the mechanistic basis for the onset of
dysregulated neutrophil activity due to hypercholesterolemia, or any pathological
condition, arises from changes in the ability of neutrophils to sense and respond to the
applied shear stresses (i.e., mechanosensitivity) in their local environment.
The cell membrane, being positioned at the interface between the extracellular
and intracellular milieu, is in a strategic position to regulate the mechanosensitivity of
many different types of cells, including the neutrophils. In general, the cell membrane is
the location for many different classes of membrane-spanning proteins, including various
GPCRs, tyrosine kinase receptors, ion channels, and integrins [23,88-94]. Many of these
proteins that have regions both inside and outside the cell have been proposed to serve as
mechanosensors and/or mechanotransducers for a variety of cells, including endothelial
cells, bone cells, and neutrophils [91,92,94].

2.5.1 Evidence of formyl peptide receptors as neutrophil mechanosensors
In the case of neutrophils, FPR has been implicated as a mechanosensor, which
drives their downstream responses to shear (e.g., actin depolymerization, pseudopod
retraction). Using HL60 derived neutrophilic cells, FPR was demonstrated as an important
component of the FSS-induced pseudopod retraction response [92]. In fact, FPR expression
alone appeared enough to confer the ability of HL60 cells to exhibit a pseudopod retraction
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response to FSS. Specifically, while undifferentiated HL60 cells express low levels of FPR
and lack the ability to form pseudopods, overexpressing FPR in HL60 cells imparted the
ability to form pseudopods that retract under FSS exposure. Moreover, HL60 cells were
prevented from retracting pseudopods by using siRNA to silence FPR expression [92].
While the exact involvement of FPR in mechanotransduction processes remains
unknown, it appears as though FSS downregulates the surface expression of this receptor
[63]. This downregulation does not involve the proteolytic activity of matrix
metalloproteinases (MMPs) [64], which are capable of cleaving FPR [69]. Instead, it seems
to involve FSS-induced internalization and relocalization of FPR from the surface to a
perinuclear compartment, thereby reducing pseudopod activity [63]. It is interesting to
note, however, that some FPRs must be present on the cell surface to regulate pseudopod
activity, since proteolytic FPR cleavage impairs the FSS-induced retraction response in
SHRs [69]. These findings further support the role of FPRs as neutrophil mechanosensors.

2.5.2 Evidence of CD18 integrins as neutrophil mechanosensors
In addition to FPR, the CD18 integrins expressed on neutrophils may also act as
mechanosensors. When exposed to FSS, CD18 integrins undergo conformational shifts in
their extracellular domains [93]. Reportedly, this structural activity is proposed to facilitate
ctsB access to cleavage domains on the CD18 integrins (Fig. 2.4). Simultaneously, it may
promote outside-in signaling capable of altering neutrophil activity. There is substantial
literature evidence suggesting that CD18 integrins influence cell functions via inside-out
as well as outside-in signaling [95,96]. There is also evidence that CD18 integrins play a
role in FSS-induced mechanosignaling. For example, neutrophils adhered to substrates
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through CD18 [97] have a functional pseudopod retraction response to FSS. Neutrophils
adherent via β1 integrins do not. This suggests that integrin specificity plays a role in FSS
mechanotransduction responses, further implicating CD18 as a potential mechanosensor.
The reported FSS-induced conformational shifts in CD18 integrins appear to serve
as a way for neutrophils to restrict their adhesive capacity. As such, a major consequence
of CD18 integrin conformational shifts may be the minimization of neutrophil adhesion.
Overall, the collective evidence for neutrophil mechanosensitive receptors, such as FPR
and CD18, points to a link between neutrophil shear sensitivity and the expression of these
membrane mechanoreceptors.

2.5.3 The cell membrane is involved in the regulation of neutrophil mechanosensitivity
Since the cell membrane acts as the substrate for all transmembrane
mechanosensitive proteins, it is conceivable that the mechanical properties of the cell
membrane may also be capable of regulating neutrophil responsiveness to FSS. In
particular, the fluidity of the cell membrane may affect mechanosensitivity by impacting
the shear-related structural activity of transmembrane mechanoreceptors.
Membrane fluidity is a measure of the lipid bilayer microviscosity, which
influences the motion and conformational activity of the other phospholipids and resident
signaling molecules such as cell surface protein receptors. Membrane fluidity changes may
alter the dynamics of membrane protein activity by affecting their intermolecular actions
or structural activity. In fact, changes in the membrane fluidity of cells have been reported
to influence the number, affinity, lateral mobility, and conformational activity of
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membrane receptors [98-101]. These physiological changes in membrane fluidity may
arise, in part, due to the actions of cholesterol on the cell membrane (Fig. 2.4)

Figure 2.4. Mechanisms by which membrane cholesterol enrichment may impair
neutrophil fluid shear stress mechanotransduction.
Pathologic cholesterol elevations can lead to the enrichment of neutrophil membranes with
cholesterol. This may alter neutrophil mechanosensitivity by affecting the ability of membrane
receptors to response to shear. Alternatively, membrane cholesterol enrichment may interfere
with the ability of neutrophils to release lysosomal proteases (such as ctsB) under shear.

Cholesterol is a regulator of membrane fluidity [102] capable of affecting
neutrophil mechanosensitivity by altering the fluidity of the cell membrane. When
extracellular cholesterol is integrated into the membrane, it causes the membrane to
become more rigid and less fluid [103,104]. This has consequences for processes that
depend on the fluidity of the cell membrane. For example, membrane cholesterol has been
shown to disrupt the signaling of lipid rafts that regulate various neutrophil functions (e.g.,
chemotaxis/migration, adhesion, etc.) [105]. Furthermore, conformation-dependent
receptors, such as GPCRs, reportedly display altered structural activity in response to
ligand binding when cellular membrane fluidity is altered [88]. This suggests that, similar
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to GPCRs, neutrophil FSS mechanosensors may have difficulty adopting changes in
conformation under shear exposure due to membrane fluidity changes (Fig. 2.4).
In addition to affecting the conformational activity and signaling of
mechanosensitive receptors, cholesterol-related changes in membrane fluidity may also
impair the release of bioactive molecules produced within the neutrophil. In support of this,
membrane stiffening has been demonstrated to interfere with the release of proinflammatory cytokines into the extracellular milieu [106]. This suggests that the
transmembrane release of ctsB, which is required to cleave CD18 integrins, may be
prevented by membrane fluidity changes associated with cholesterol enrichment (Fig. 2.4).
Taken together, it is conceivable that the actions of hypercholesterolemia on the
neutrophil membrane interfere with a critical regulatory mechanism (i.e., FSS
mechanotransduction) charged with ensuring neutrophils remain inactivated. In doing so,
this may lead to the neutrophils becoming more adhesive, resulting in their sustained
retention in the microvasculature with a detrimental impact on the microcirculation. This
possibility is the focus of the investigations in the present dissertation.

2.6 Study Rationale
Recently, our lab reported neutrophil mechanosensitivity to be a function of the
cholesterol-related fluidity of the cell membrane [27]. We also determined that cholesterolrelated impairment of FSS-induced pseudopod retraction was correlated with tissue blood
flow dysregulation in hypercholesterolemic mice [26]. However, the pathogenic
mechanism that connects impaired FSS sensitivity, neutrophil dysregulation, and
microvascular dysfunction due to hypercholesterolemia remains to be determined.
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The present study explored a new pathogenic mechanism by focusing on how
membrane fluidity changes may affect the FSS mechanoregulation of CD18 integrin
expression. In doing so, the present study sought to not only determine how ctsB-induced
CD18 cleavage regulated neutrophil adhesion to vascular endothelium, but also examine
how membrane cholesterol enrichment may impair FSS mechanotransduction and whether
it may serve as a potential mechanistic link between dysregulated neutrophil adhesion and
microvascular dysfunction, two key features of hypercholesterolemia.
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CHAPTER 3: CHARACTERIZATION OF THE FLUID SHEAR STRESSINDUCED CLEAVAGE OF CD18 INTEGRINS BY CATHEPSIN B RELEASE
FROM NEUTROPHIL-LIKE CELLS
Neutrophils proteolytically shed the extracellular domains of surface-associated
CD18 integrins when exposed to FSS under physiologic conditions [23,59,93]. This occurs
through FSS-induced release of the cysteine protease ctsB, which targets CD18 in the
ectodomain. However, it is not known which of the CD18 integrin heterodimers (i.e., either
LFA1, Mac1, CD11c/CD18, or CD11d/CD18) is cleaved by ctsB.
The present study sought to elucidate further mechanistic insight regarding the role
of ctsB in the FSS regulation of CD18 integrin surface expression by neutrophils. Since all
of the possible CD18-containing integrins have different roles during leukocyte
recruitment and adhesion to the endothelium, the integrin specificity of ctsB was expected
to provide a clue as to how FSS-induced CD18 cleavage deactivated the cell.
The present study also sought to verify whether FSS mechanotransduction is a
characteristic of the neutrophilic phenotype. HL60-derived neutrophil-like cells (dHL60NCs) have been used to model neutrophil migration and chemotaxis [107]. Furthermore,
dHL60-NCs also exhibit shear sensitivity, as these cells retract pseudopods when exposed
to FSS [92,108]. The studies outlined in this section focused on characterizing and
verifying that, in response to FSS exposure, dHL60-NCs release ctsB and cleave CD18
integrins similar to primary human neutrophils. The CD18 integrin cleavage responses of
human neutrophils and dHL60 cells were compared to also determine if dHL60 cells would
serve as a suitable transfection culture model for planned studies.
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We exposed human neutrophils and dHL60-NCs to shear using a cone-and-plate
viscometer. Using both cells, we analyzed the FSS-induced cleavage response for LFA1
and Mac1 in the presence of protease inhibitors. Additionally, we also analyzed the
expression of CD11c on dHL60-NCs. Since dHL60-NCs upregulate CD11a and CD11b
after differentiation [109], we wanted to ensure that other CD18 heterodimers were not
being upregulated as well. We excluded CD11d from our analyses, as prior studies
indicated that expression of this integrin is primarily limited to macrophages [110,111].
Finally, we stimulated cells with different concentrations of fMLP to determine whether
inflammatory stimulation overrides FSS-induced CD18 cleavage.

3.1 Methods
3.1.1 Cells
3.1.1a Human neutrophils
Human subject recruitment, informed consent, and phlebotomy were approved by
the University of Kentucky Institutional Review Board. Blood samples were harvested
from asymptomatic human volunteers into K2-EDTA-coated vacutainers (BectonDickinson) by standard venipuncture, as reported [27]. Neutrophils were then isolated by
two-step Histopaque-Percoll gradient centrifugation and resuspended in Hank’s balanced
salt solution (HBSS) containing calcium and magnesium, as reported [93]. These purified
cell suspensions were estimated to contain >90% neutrophils.
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3.1.1b HL60-derived neutrophilic cells
HL60 cells (CCL-240; ATCC) were cultured in RPMI-1640 media (Invitrogen)
supplemented

with

10%

fetal

bovine

serum

(FBS;

Hyclone)

and

1%

penicillin/streptomycin/L-glutamine (PSG; Mediatech) under standard incubation
conditions (i.e., a humidified, 5% CO2/95% air environment maintained at 37°C) according
to the manufacturer’s instructions. To induce a neutrophilic phenotype, HL60 cells (1x106
cells/mL) were differentiated in neutrophilic induction media consisting of RPMI-1640
media supplemented with 10% FBS, 1% PSG, and 1.25% dimethyl sulfoxide (DMSO;
Sigma-Aldrich). HL60 differentiation proceeded over a period of 5 days as reported
[92,108], with fresh neutrophilic induction media being replaced after 3 days. After HL60
cells were completely differentiated into dHL60-NCs, the cells were washed twice in PBS
and then allowed to recover in DMSO-free culture medium for 1 hour prior to their use.

3.1.2 Cone-and-plate shear exposure
A custom cone-and-plate viscometer with a cone angle of 1° was used to expose
aliquots (1 mL) of human neutrophils or dHL60-NCs to a constant laminar shear stress
field of 5 dyn/cm2 for 10 minutes as previously reported [27]. To achieve the desired shear
stress of 5 dyn/cm2 while assuming a viscosity of ~0.01 P, the cone was set to rotate at a
rate of 82 rpm over a 10 minute period (Fig. 3.1). This was determined by using the
following equation to calculate the shear stress applied by the cone-and-plate viscometer:
𝜏𝜏 =

𝜇𝜇 × 2𝜋𝜋𝜋𝜋
60 sin 𝜃𝜃

where τ is shear stress (dyn/cm2), μ is viscosity (P), ω is the rotational rate of the cone
(rpm), and θ is the angle of the cone (degrees).
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Figure 3.1. Representative diagram of a cone-and-plate viscometer.
By using a cone-and-plate viscometer, cell suspensions can be exposed to a uniform shear
stress. The applied shear stress depends on the shallow cone angle, rotational rate, and
viscosity of the solution.

Additional chemical treatments were performed on cells prior to, or during, shear
exposure to test the involvement of the mechanisms of interest regarding FSS-induced
CD18 cleavage. For experiments conducted with protease inhibitors, human neutrophils
were pretreated with and without 30 µM E64 (cysteine protease inhibitor), 50 µM CA074me (ctsB inhibitor) or 5 µM aprotinin (AP; negative control inhibitor) for 5 minutes prior
to shear exposure as reported [112]. Similarly, dHL60-NCs were pretreated with 30 μM
E64, 5 μM aprotinin, or 1 μM pepstatin (aspartyl protease inhibitor) for 5 minutes, or 50
mM doxycycline (MMP inhibitor) for 30 minutes. For experiments conducted with
inflammatory agonists, human neutrophils and dHL60-NCs were pretreated with or
without 0.01 – 10 μM fMLP for 10 minutes.
Once human neutrophils or dHL60-NCs were pretreated for the appropriate
duration of time, the cells were kept in HBSS with the inhibitory reagents and exposed to
shear using the cone-and-plate viscometer. Controls were parallel cell populations
maintained under static (i.e., no-FSS), but otherwise similar experimental, conditions. In
this case, the cone was held stationary while cells were allowed to incubate on the plate.
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Immediately after shear and control experiments, cells were fixed (1% p-formaldehyde in
phosphate buffer) for 15 minutes. After fixation, cell populations were washed three times
in PBS and prepared for immunofluorescence.

3.1.3 Immunofluorescence
Fixed human neutrophils or dHL60-NCs were resuspended in 1% bovine serum
albumin (BSA) in PBS for 30 minutes and subsequently labeled with fluorescent antibodies
for one hour using standard immunochemistry. Some cell populations were left
unpermeabilized to assess surface expression, while other cell populations were
permeabilized to assess intracellular expression by adding 0.1% saponin to the 1% BSA
buffer prior to fluorescent antibody labeling. After fluorescent labeling, cell suspensions
were washed three times in PBS to remove unbound antibodies and subsequently
resuspended in PBS for flow cytometric analyses.
For analysis of surface integrin expression on human neutrophils and dHL60-NCs,
FITC-conjugated mouse monoclonal antibody (mAb) to CD18 (clone 6.7), PE-conjugated
mouse mAb to CD11a (clone 38), or Alexa Fluor 488-conjugated mouse mAb to CD11b
(clone ICRF44) were used to label unpermeabilized cells as reported [59]. Some dHL60NCs were also labeled with FITC-conjugated mouse mAb to CD11c (clone B-ly6). For
analysis of total cellular CD18 levels (i.e., cleaved and uncleaved integrins), permeabilized
dHL60-NCs were labeled with goat polyclonal antibody (pAb) against the intracellular
domain for CD18 (clone C-20) in conjunction with an Alexa Fluor 488-conjugated donkey
anti-goat IgG (i.e., secondary) antibody (Invitrogen). Nonspecific binding was quantified
using an Alexa Fluor 488-conjugated mouse IgG1 isotype control (Invitrogen).
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For analysis of ctsB expression in human neutrophils and dHL60-NCs, cells were
labeled with rabbit pAb (clone Ab-3) in conjunction with an Alexa Fluor 488-conjugated
goat anti-rabbit IgG (i.e., secondary) antibody (2 mg/mL; Invitrogen). Cells were left
unpermeabilized to assess surface ctsB expression, while some cells were permeabilized
using 0.1% saponin to assess total ctsB expression. Nonspecific binding was quantified
using an Alexa Fluor 488-conjugated mouse IgG1 (Invitrogen) and an Alexa Fluor 488conjugated goat IgG1 (Santa Cruz Biotechnology).

3.1.4 Flow cytometry
Flow cytometric analyses utilized an LSR II flow cytometer (Becton-Dickinson)
interfaced with Becton-Dickinson FACsDiva software, as previously reported [59].
Neutrophil and dHL60-NC populations were gated based on their forward scatter (FSC)
and side scatter (SSC) values. The total fluorescence intensity, representing the amount of
bound antibodies, was used as the measure of antigen specific expression level. By using
the total fluorescence intensity, histograms of antigen-specific fluorescence intensity were
generated for each sample using the FCS Express 4 Flow Cytometry software (De Novo
Software). Shear-induced changes in the antigen expression levels were normalized to
those of their respective controls and expressed as “fold change”.
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3.1.5 Statistics
Quantitative data derived from dHL60-NCs and human neutrophils were expressed
as mean ± standard error of the mean (SEM) for n ≥ 3 replicates. Statistical analyses were
performed using the statistical software program JMP (SAS Institute). One-sample t-tests
with P < 0.05 were used to identify significant fold changes or percent reductions in
experimental treatments compared to a reference value. Comparisons between the means
of experimental treatments (i.e. unstimulated cells vs. chemically-pretreated cells) were
performed using ANOVA and post-hoc Tukey’s test with P < 0.05 indicating significance.

3.2 Results
3.2.1 Fluid shear stress-induced cathepsin B release selectively cleaves Mac1 in human
neutrophils
Human neutrophils left untreated (UNT) and exposed to FSS (5 dyn/cm2 for 10
min) with a cone-plate device exhibited reduced binding of antigen-specific antibodies to
CD18 and CD11b, but not CD11a integrins relative to time-matched, unsheared controls
(Fig. 3.2, A – C). This reduction in CD18 antibody binding was blocked for cells pretreated
with CA074, but not AP (our negative control protease), prior to shearing (Fig. 3.2, D).
CA074 and AP had no effect on binding of CD11a antibodies to neutrophils after control
or FSS experiments (Fig. 3.2, E). Notably, FSS-induced reductions in CD11b antibody
binding to neutrophils were mitigated by CA074, but not by AP (Fig. 3.2, F).
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Figure 3.2. The selective cleavage of Mac1 by shear-induced cathepsin B release.
(A-C) Representative flow cytometry histograms depicting the fluorescent intensity of intact
CD18 (A), CD11a (B), and CD11b (C) expressed on the surface of neutrophil suspensions
maintained under no-flow conditions (thick black line) or subjected to 5 dyn/cm2 shear stress
(hatched shading) using a cone-and-plate viscometer. A negative (IgG) staining control is also
displayed in each plot (dark gray shading). Neutrophil suspensions were treated with or
without ctsB-specific inhibitor CA074 (50 µM) and serine inhibitor aprotinin (AP; 5 µM). (DF) Based on florescent antibody binding, mean fluorescent intensities of sheared neutrophils
were normalized to their respective no-flow controls and plotted as fold change ± SD for
CD18 (D), CD11a (E), and CD11b (F) integrins. n = 3 replicates in each group. *P < 0.05
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to control.

3.2.2 Fluid shear stress induces time-dependent cathepsin B release by human neutrophils
Permeabilized human neutrophils exhibited significantly reduced binding to ctsB
antibodies after 2.5 min of FSS exposure when compared to unsheared cells (Fig. 3.3, A).
This apparent reduction in total ctsB levels was observed for the duration of the 10 min
exposure (Fig. 3.3, C). In contrast, ctsB antibody binding to unpermeabilized human
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neutrophils remained unchanged after 2.5 and 10 min of FSS exposure (Fig. 3.3, B). While
surface-associated ctsB appeared to be significantly elevated after 5 min of FSS, the
differences in expression levels were minor (Fig. 3.3, D).

Figure 3.3. Fluid shear stress induces time-dependent cathepsin B release.
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB
expression within the cytosolic domain (A) or membrane surface domain (B) for neutrophil
suspensions maintained under no-flow conditions (thick black line) or exposed to 5 dyn/cm2
shear stress (hatched shading) using a cone-and-plate viscometer. A negative (IgG) staining
control is also displayed in each plot (dark gray shading). Shear duration was gradually
increased (2.5, 5, and 10 minutes) to observe the time-dependent effects of shear. (C-D) Based
on fluorescent antibody binding, mean fluorescence intensities of sheared neutrophils were
normalized to their respective no-flow controls and plotted as fold change ± SD for ctsB
cytosolic (C) or membrane surface (D) expression. n = 3 replicates in each group. *P < 0.05
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 2.5 minute
shear exposure. ^P < 0.05 compared to 10 minute shear exposure.

3.2.3 Exposure to shear induces CD18 cleavage in dHL60-NCs
DHL60-NCs expressed intact CD18 integrins on their surfaces under all conditions
tested in the present study (Fig. 3.4, A) as indicated by their binding affinity to mAb 6.7
relative to that of mouse IgG (negative staining control). Notably, untreated dHL60-NC
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populations exposed to 5 dyn/cm2 FSS, in the absence or presence of 0.01 μM fMLP,
exhibited significantly (P < 0.05) reduced binding of mAb 6.7 relative to cells maintained
under control (i.e., no-flow), but otherwise similar experimental, conditions. The FSSinduced reductions in cell surface affinity to mAb 6.7 were abrogated when untreated or
fMLP-stimulated dHL60-NCs were pretreated and subsequently exposed to shear with the
cysteine protease inhibitor E64. In this case, no noticeable shift in fluorescent intensity
(indicative of mAb 6.7 binding) was observed between sheared and unsheared samples
when the cells were in the presence of E64 (Fig. 3.4, B).

Figure 3.4. Fluid shear stress promotes cleavage of CD18 integrins off the surface of
dHL60-NCs.
(A) Representative flow cytometry histograms depicting the fluorescent intensity of CD18
expression on the surface of dHL60-NC suspensions maintained under no-flow conditions
(blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a cone-and-plate viscometer.
A negative (IgG) staining control is also displayed in each plot (hatched shading). DHL60-NC
suspensions were treated with or without fMLP (0.01 µM) and cysteine inhibitor E64 (30
µM). (B-C) Based on fluorescent antibody binding, mean fluorescence intensities of sheared
neutrophils were normalized to their respective no-flow controls and plotted as fold change ±
SEM for CD18 membrane surface (C) or cytosolic (D) expression. n = 4 replicates in each
group. *P < 0.05 compared to a normalized control value of 1 (dotted line). #P < 0.05
compared to control.
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Untreated dHL60-NC populations exposed to FSS, whether in the absence or
presence of 0.01 µM fMLP, did not exhibit reductions in the binding of pAb C-20 antibody
against the cytoplasmic domains of CD18 integrins (Fig. 3.4, C). Similarly, untreated or
fMLP-stimulated dHL60-NCs that were pretreated with E64 also did not exhibit a
reduction in affinity to pAb C-20 when exposed to FSS. In both cases, the cytoplasmic
CD18 integrin expression by dHL60-NCs exposed to FSS remained similar to that
expressed by dHL60-NCs maintained under control (i.e., no-flow), but otherwise similar
experimental, conditions. Combined, these results provided evidence that shear exposure
promotes cleavage of CD18 integrins in the extracellular domain.

3.2.4 Exposure to shear induces CD11a, but not CD11b, cleavage in dHL60-NCs
Under all conditions tested in the present study, dHL60-NCs displayed detectable
surface expression levels of intact CD11a (Fig. 3.5, A) and intact CD11b (Fig. 3.5, B)
integrins. Specifically, all fluorescent intensities indicative of integrin subtype-specific
antibody binding were greater than those of cells stained with isotype-matched mouse IgG
negative control proteins.
Notably, the surfaces of dHL60-NCs exposed to FSS, in the absence or presence of
fMLP, exhibited reduced binding to mAb 38 antibodies indicative of significant (P < 0.05)
reductions in surface expression of intact CD11a relative to time-matched, unsheared
controls. This FSS-induced reduction in surface affinity for mAb 38 antibodies was
attenuated, but not completely blocked, by treatment of either untreated or fMLP-treated
cells with E64 prior to and during flow experiments (Fig. 3.5, C).
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In contrast, untreated and fMLP-treated dHL60-NCs either maintained under
control conditions or exposed to FSS exhibited similar binding affinities for mAb ICRF44
directed against the extracellular domain of CD11b (Fig. 3.5, D). Similarly, untreated or
fMLP-stimulated dHL60-NCs that were pretreated with E64 and either maintained under
control conditions or exposed to FSS also exhibited similar binding affinities for mAb
ICRF44 against CD11b. Thus, FSS exposure induced cleavage of CD11a, but not CD11b,
integrins by dHL60-NCs.

Figure 3.5. Fluid shear stress reduces surface expression of CD11a, but not CD11b, on
dHL60-NCs.
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of CD11a
(A) and CD11b (B) expression on the surface of dHL60-NC suspensions maintained under
no-flow conditions (blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a coneand-plate viscometer. A negative (IgG) staining control is also displayed in each plot (hatched
shading). DHL60-NC suspensions were treated with or without fMLP (0.01 µM) and cysteine
inhibitor E64 (30 µM). (C-D) Based on fluorescent antibody binding, mean fluorescence
intensities of sheared dHL60-NCs were normalized to their respective no-flow controls and
plotted as fold change ± SEM for CD11a (C) or CD11b (D) expression. n = 4 replicates in
each group. *P < 0.05 compared to a normalized control value of 1 (dotted line). #P < 0.05
compared to control + 30 µM E64.
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3.2.5 DHL60-NCs do not express the CD11c integrin on their surface
DHL60-NCs are capable of upregulating their expression of CD11a and CD11b
integrins during differentiation [109]. We wanted to ensure that other CD18 heterodimers,
such as CD11c, were not expressed on dHL60-NCs. As such, we investigated the
possibility that CD11c/CD18 integrins were cleaved by dHL60-NCs in response to shear
exposure. However, our analyses revealed that dHL60-NCs, either maintained under
control conditions or exposed to FSS, did not exhibit detectable surface expression of
CD11c integrins. Specifically, there was no detectable difference in the surface binding
affinity of unsheared and sheared dHL60-NCs to either mAb B-Ly6 or mIgG negative
staining control protein (Fig. 3.6, A). Moreover, treatment of cells with fMLP and/or E64,
both with or without FSS exposure, had no effect on the membrane surface expression
levels of CD11c integrins (Fig. 3.6, B).

Figure 3.6. DHL60-NCs do not express the CD11c integrin.
(A) Representative flow cytometry histogram depicting the fluorescent intensity of CD11c
expression on the surface of dHL60-NC suspensions maintained under no-flow conditions
(blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a cone-and-plate viscometer.
A negative (IgG) staining control is also displayed in each plot (hatched shading). DHL60-NC
suspensions were treated with or without fMLP (0.01 µM) and cysteine inhibitor E64 (30
µM). (B) The mean fluorescence intensities used to quantify binding of mAb B-ly6 to dHL60NCs were plotted as CD11c expression level ± SEM. n = 3 replicates in each group.
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3.2.6 DHL60-NCs display minimal expression of cathepsin B
In comparison to human neutrophils, dHL60-NCs displayed low to minimal surface
and cytosolic levels of ctsB (Fig. 3.7, A – B). On average, human neutrophils displayed
binding affinities to pAb Ab-3 that were significantly greater than that of the secondary
Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody alone, both on their cell surface
as well as within their cytoplasm (Fig. 3.7, C). In contrast, the binding affinities of dHL60NCs to pAb Ab-3, either on the cell surface or within the cytoplasm, were comparable to
their binding affinities to the secondary antibody alone (Fig. 3.7, D).

Figure 3.7. Human neutrophils, but not dHL60-NCs, express cathepsin B.
(A-B) Representative flow cytometry histogram depicting the fluorescent intensity of ctsB
expression on the surface of human neutrophil (A) or dHL60-NC (B) suspensions maintained
under no-flow conditions (blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a
cone-and-plate viscometer. A negative (IgG) staining control is also displayed in each plot
(hatched shading). (C-D) Based on fluorescent antibody binding, mean fluorescence
intensities of sheared cells were normalized to their respective no-flow controls and plotted as
ctsB expression level ± SEM for human neutrophils (C) or dHL60-NCs (D). n = 3 replicates
in each group. *P < 0.05 compared to secondary antibody.
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3.2.7 Shear-induced CD11a/CD18 cleavage may involve multiple proteases, including
cysteine proteases, for dHL60-NCs
DHL60-NCs treated with serine and aspartyl protease inhibitors (aprotinin and
pepstatin, respectively) prior to, and during, FSS exposure exhibited significant reductions
in binding affinities for antibodies directed against the extracellular domains of CD18 and
CD11a, relative to their respective time-matched, unsheared controls (Fig. 3.8, A – B).
Notably, while doxycycline completely inhibited FSS-induced reductions in dHL60
binding to mAb 6.7 against CD18, it only partially blocked FSS-induced reductions in
binding to mAb 38 against CD11a. This same pattern of blocking was observed for E64.
Thus, the reduced surface expression of intact CD11a and CD18 integrins by dHL60-NCs
exposed to shear occurred independently of aspartyl, serine, and MMP-9 proteases. This
implicates a cysteine protease in the FSS-induced reductions of CD11a.

Figure 3.8. Fluid shear stress-induced reductions in CD18 and CD11a surface expression
involve cysteine proteases for dHL60-NCs.
(A-B) Mean fluorescence intensities (MFI) used to quantify reductions in CD18 (A) or CD11a
(B) expression by dHL60-NCs after exposure to 5 dyn/cm2 shear stress in the absence
(control; white bars) or presence (black bars) of protease inhibitors were normalized to their
respective controls and plotted as average fold change ± SEM. The following protease
inhibitors were tested: 5 μM aprotinin (AP), 1 μM pepstatin (PEP), 30 μM E64 (cysteine
inhibitor), or 50 mM doxycycline (DOX). n = 3 replicates in each group. *P < 0.05 compared
to a normalized control value of 1 (dotted line). #P < 0.05 compared to E64. ^P < 0.05
compared to DOX.
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3.2.8 Cell agonist fMLP dose-dependently suppresses shear-induced cleavage of CD18
integrins in neutrophil-like cells
Untreated dHL60-NCs, as well as cells stimulated with 0.01 µM fMLP, exhibited
significant reductions in CD18 surface expression in response to FSS exposure. However,
this response was attenuated, and completely blocked, when stimulated with 1 and 10 µM
fMLP, respectively (Fig. 3.9, A). Additionally, CD11a surface expression by dHL60-NCs
was significantly reduced after exposure to FSS under all concentrations of fMLP tested
(Fig. 3.9, B). The post-shear reduction in CD11a surface expression, however, was
attenuated at higher fMLP concentrations (1 and 10 µM).
Similarly to dHL60-NCs, untreated human neutrophils, as well as human
neutrophils stimulated with 0.01 µM fMLP, exhibited significant reductions in CD18
surface expression in response to FSS. However, this response was attenuated, and
completely blocked, when stimulated with 1 and 10 µM fMLP, respectively (Fig. 3.9, C).
In the case of the CD11 subunits, CD11b surface expression by human neutrophils was
significantly reduced after exposure to FSS in the presence of 0 – 0.01 µM fMLP (Fig. 3.9,
D). The post-shear reduction in CD11b surface expression, however, was attenuated at
higher fMLP concentrations (1 and 10 µM). These results suggest that high levels of
inflammatory agonists may be capable of overriding the FSS-induced cleavage of CD18
and CD11 integrins.
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Figure 3.9. The inflammatory agonist fMLP dose-dependently attenuates shear-induced
CD18 cleavage in neutrophil-like cells.
(A-B) Mean fluorescence intensities (MFI) used to quantify reductions in CD18 (A) or CD11a
(B) expression by dHL60-NCs after exposure to 5 dyn/cm2 shear stress in the absence
(control; white bars) or presence (black bars) of fMLP were normalized to their respective
controls and plotted as average fold change ± SEM. FMLP was used at 0, 0.01, 1, and 10 μM
concentrations. (C-D) Mean fluorescence intensities (MFI) used to quantify reductions in
CD18 (C) or CD11b (D) expression by human neutrophils after exposure to 5 dyn/cm2 shear
stress in the absence (control; white bars) or presence (black bars) of fMLP were normalized
to their respective controls and plotted as average fold change ± SEM. FMLP was used at 0,
0.01, 1, and 10 μM concentrations. n = 3 replicates in each group. *P < 0.05 compared to a
normalized control value of 1 (dotted line). #P < 0.05 compared to 10 μM fMLP. ^P < 0.05
compared to 1 μM fMLP.

3.2.9 Summary of findings/interpretations
The results of the present study provided evidence for the following significant findings.
•

FSS-induced CD18 cleavage is characteristic of neutrophil-like cells, which
suggests this is a key mechanoregulatory control mechanism for neutrophils.

•

FSS-induced release of ctsB selectively cleaves Mac1, suggesting FSS
mechanotransduction serves to restrict firm neutrophil adhesion.
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•

FSS-induced CD18 cleavage appears to be anti-inflammatory and can be
overridden by high levels of inflammatory agonists.

•

FSS-induced CD18 cleavage is a characteristic response of neutrophil-like cells to
FSS exposure.

•

The dHL60-NC culture model may be used as a transfectable cell line for the
purpose of mechanistic-based explorations of FSS mechanotransduction for
neutrophils.
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CHAPTER 4: EVALUATING THE ROLE OF FLUID SHEAR-INDUCED
CATHEPSIN B RELEASE IN THE CONTROL OF MAC1-DEPENDENT
NEUTROPHIL ADHESION
Because our previous experiments established a role for ctsB in the cleavage of
Mac1 under FSS exposure, we wanted to investigate the possibility that this protease
regulates Mac1-related neutrophil adhesive processes. In vivo, neutrophils firmly adhere to
platelets, other leukocytes, and endothelium using Mac1 [12,113,114]. Expression of Mac1
is important, as Mac1-knockout mice are associated with neutrophils that exhibit a
markedly reduced adhesive capability, particularly during inflammation [115,116].
Additionally, Mac1-deficient neutrophils exhibit reduced migration rates [117]. Because
neutrophil migration involves the projection and retraction of pseudopods which utilize
Mac1 for stabilization [117], we sought to determine how ctsB could modulate Mac1dependent neutrophil pseudopod activity during migration under no-flow conditions. We
did so using exogenous ctsB or ctsB inhibitors as well as dHL60-NCs overexpressing ctsB.
Mac1 integrins are also critical for the arrest/firm adhesion of neutrophils to
microvasculature under flow conditions [118,119]. Since Mac1 is cleaved under FSS
exposure by ctsB release, the experiments in the present study sought to determine how
FSS mechanotransduction played a role in the control of Mac1-dependent neutrophil
adhesion under flow. To accomplish this, we allowed neutrophils to adhere to platelet and
endothelial cell monolayers and exposed them to flow to monitor their detachment as an in
vitro test of the FSS regulation of neutrophil adhesion. By pretreating neutrophils with ctsB
inhibitors, we could evaluate the importance of ctsB in regulating neutrophil adhesion
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under these flow conditions. Collectively, the goal of the studies described in this chapter
was to evaluate the role of ctsB in the control of neutrophil adhesive capacity.

4.1 Methods
4.1.1 Cells
4.1.1a Human neutrophils and platelets
Human neutrophils were purified from whole blood harvested from asymptomatic
volunteers as described in section 3.1.1a. Approximately 5 mL of whole blood was also set
aside to purify platelets for use in flow-based detachment assays (see section 4.1.3) that
were used to quantify the ability of FSS to restrict neutrophil adhesion. Platelets were
extracted from plasma by removing erythrocytes and leukocytes through low speed
(100xg) centrifugation, washing the supernatant solution in HEPES buffer, and suspending
the platelets in Tyrode’s buffer, according to detailed procedures [120].

4.1.1b Human cell culture
HL60 cells were cultured as previously described in section 3.1.1b. Differentiation
of HL60 cells into dHL60-NCs also occurred as previously described in section 3.1.1b. On
day 4 of differentiation, however, dHL60-NCs were transiently transfected with a ctsBgreen fluorescent protein (ctsB-GFP) expression vector. Transfections were carried out
using a Lonza Nucleofector Electroporator with the preset program T-019 and following
the manufacturer’s instructions. After transfection, dHL60-NCs were cultured in
neutrophilic induction media for the remaining fifth day.
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Human umbilical vein endothelial cells (HUVECs; Lifeline Cell Technology) were
cultured in VascuLife VEGF media (Lifeline Cell Technology) supplemented with 10%
FBS and 1% PSG, according to the manufacturer’s instructions. The HUVECs were grown
under standard incubation conditions described in section 3.1.1b. HUVECs were passaged
approximately every three days to maintain optimal growth. These cells were used for
flow-based cell detachment assays (see section 4.1.3) to quantify FSS regulation of
neutrophil adhesion.

4.1.2 Pseudopod activity analysis
Glass slides were cleaned prior to experimentation using separate incubations in
acetone and 70% ethanol in an ultrasonic cleaner for 15 minutes each. The glass substrates
were then treated with 1 N NaOH for 2 hours to generate a hydrophobic surface conducive
for cell adhesion and then pre-coated with fetal bovine serum for 10 minutes. For
experiments, neutrophils and dHL60-NCs were pretreated for 5 min with and without 1
μM fMLP, 0.5 U/mL ctsB, or 50 µM CA074 and then deposited (at a density of 1x106/mL)
on the FBS-coated glass slides for 20 min. Non-adherent cells were rinsed with PBS, and
the remaining adherent cells were maintained under no-flow conditions in HBSS. Bright
field micrographs of neutrophils, as well as bright field and fluorescence images of ctsBGFP transfected cells, were acquired every 15 s for 10 min using an Olympus IX-71
fluorescence microscope.
To calculate cell centroid displacement rates, ImageJ was used to manually trace
individual cells and track the movement of their centroid between consecutive frames
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[121]. The centroid displacement rate, calculated by the following equation, was used as a
surrogate measure of dynamic cell shape changes due to pseudopod activity:
�(x2 − x1 )2 + (y2 − y1 )2
Centroid displacement rate (CDR) =
t

where x1 is the initial x coordinate, x2 is the final x coordinate, y1 is the initial y coordinate,
y2 is the final y coordinate, and t is the time between frames (Fig. 4.1, A).

Figure 4.1. Representative images of centroid displacement and pseudopod projection
analyses.
(A) The rate of cell migration was calculated as the rate of centroid displacement. The black
solid arrow represents the migration path of a neutrophil over a specific duration of time. The
red dashed arrow represents the centroid displacement rate (CDR) of the neutrophil over that
same duration of time. (B) The rate of pseudopod projection or retraction was calculated by
dividing the major axis length of a pseudopod by the interval of time necessary to achieve this
length. The red arrow represents the major axis length of a pseudopod.

To calculate the rates of pseudopod extension and retraction, ImageJ was used to
analyze selected pseudopod projections (Fig. 4.1, B). First, the major axis length of a
pseudopod projection was calculated. Then, the duration of time it took for the pseudopod
to achieve this length was measured over several consecutive frames. For pseudopod
projection, the initial time point was determined to be when a pseudopod emerged from
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the cell membrane, and the final time point was estimated to be when the same pseudopod
achieved its major axis length. For pseudopod retraction, the initial time point was when
the pseudopod was at its major axis length, and ended once the pseudopod had fully
retracted. The corresponding rate of projection or retraction was then calculated by dividing
the maximum pseudopod length by the duration of time.

4.1.3 Neutrophil detachment assay
Detachment assays were conducted using autologous human platelets that had been
deposited on cleaned glass slides (described in section 4.1.2) and allowed to spread into a
uniform coating for 30 min following previously-reported procedures [122]. A flow
channel was assembled by interfacing the platelet-coated slides to a polycarbonate base
having inlet and outlet ports (Fig. 4.2). A pre-cut gasket separating these two components
formed a 200-µm high parallel plate flow channel. We selected a parallel plate flow
chamber for experimental analyses to expose cells to a constant laminar shear stress over
a given duration of time. This ensured that cell detachment under FSS exposure would be
due to mechanoregulatory processes at our defined shear stress magnitude.
Detachment assays were also conducted using HUVECs seeded (5 x 105/mL) and
grown on fibronectin-coated culture surfaces of 17 (l) x 3.8 (w) mm Ibidi microslides
(VI0.4; 400-µm high channel) for 3 days as reported [123]. The Ibidi microslides offered a
sterile culture environment to grow HUVEC monolayers to confluency, and have been
used in previous flow-based assays to maintain sterility [123,124]. Furthermore, the
dimensions of the Ibidi microslides enabled us to achieve the same shear stress magnitude
as our custom parallel plate flow system.
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Figure 4.2. Schematic representation of the flow-based detachment assay.
This diagram represents the flow-based detachment assay for platelet-coated glass slides.
HBSS is perfused into the chamber using the syringe pump.

For flow studies, neutrophils (5x106/mL) were pretreated with and without 1 µM
fMLP, 30 µM E64, 50 µM CA074-me, or 5 µM AP for 5 min and deposited on the platelet
or HUVEC monolayers for 10 min, after which the non-adherent cells were rinsed away.
A syringe pump was used to perfuse HBSS through the chamber to impose a FSS of 5
dyn/cm2 on the wall of the channel. The flow rate was adjusted to impose 5 dyn/cm2 as
calculated according to the following equation:
Flow rate (𝑄𝑄) =

τw bh2
6µ

where τw is wall shear stress, b is the channel width, h is the channel height, and μ is the
perfusate viscosity. Bright field micrographs (100X magnification) of the neutrophils were
acquired every 5 s for 10 min, and neutrophil detachment was estimated by normalizing
the number of neutrophils visible in each image against that present 30 seconds after flow
initiation. We defined this initial time point to be t = 0 to ensure non-adherent cells were
rinsed away prior to analyses.
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4.1.4 Statistics
Quantitative data derived using human blood-derived neutrophils and dHL60-NCs
cells were expressed as mean ± standard deviation (SD) for n ≥ 3 replicates. Statistical
analyses were performed using JMP software (SAS Institute). One-sample t-tests with P <
0.05 were used to identify significant fold changes or percent reductions in experimental
treatments compared to a reference value. Comparisons between the means of experimental
treatments were performed using ANOVA and post-hoc Tukey’s test with P < 0.05
indicating significant differences.

4.2 Results
4.2.1 Cathepsin B enhances human neutrophil pseudopod activity
Human neutrophils were treated with exogenous ctsB in order to determine how
Mac1-dependent neutrophil migration may be affected by proteolytic cleavage. Compared
to untreated human neutrophils, those treated with exogenous ctsB (Fig. 4.3, A) displayed
significantly elevated cell centroid displacement rates consistent with increased pseudopod
activity (Fig. 4.3, B). The observed ctsB-mediated increases in pseudopod activity were
attenuated by CA074. Notably, ctsB stimulated a greater increase in pseudopod retraction
rates (by 2 to 2.5 fold over untreated cells) than in pseudopod extension rates (by
approximately 1.5 fold over untreated cells) (Fig. 4.3, C). CA074 attenuated the effects of
ctsB. Combined, these data are consistent with ctsB enhancing the pseudopod activity of
neutrophils, likely through an effect involving Mac1 cleavage during pseudopod retraction.
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Figure 4.3. The influence of cathepsin B on neutrophil pseudopod activity.
(A) Representative images of migrating neutrophils adhered to glass slides and maintained
under no-flow conditions. Untreated neutrophils were quiescent and formed few pseudopods.
CtsB-stimulated neutrophils rapidly formed and retracted many pseudopods, some of which
are observed in the representative images. (B) Neutrophil migration was quantified as mean
centroid displacement rate (MCDR) over a 15 seconds and plotted as mean ± SD, based on
cell tracings performed using ImageJ software. Neutrophils were treated with or without
exogenous ctsB (0.5 u/mL) and ctsB-specific inhibitor CA074 (5 µM). n = 3 replicates in each
group. *P < 0.05 compared to control. #P < 0.05 compared to CA074. (C) Neutrophil
pseudopod activity during migration was quantified as mean pseudopod displacement rate
(MPDR) based on manual tracings of projecting (white bars) or retracting (gray bars)
pseudopods using ImageJ software. Neutrophils were treated with or without exogenous ctsB
(0.5 u/mL) and ctsB-specific inhibitor CA074 (5 µM). n = 3 replicates in each group. *P <
0.05 compared to control (projection). ^P < 0.05 compared to control (retraction). #P < 0.05
compared to CA074 (projection and retraction). Scale bars are 10 µm.

4.2.2 Cathepsin B enhances dHL60-NC pseudopod activity
To further assess the potential influence of ctsB on pseudopod activity, dHL60
neutrophil-like cells were transiently transfected with ctsB-GFP expression plasmids.
These cells displayed GFP fluorescence (Fig. 4.4, A), indicating that transfected cells were
overexpressing ctsB-GFP. Cells transfected with empty vectors (EV) exhibited no GFP
fluorescence (Fig. 4.4, B). The EV transfectants exhibited baseline cell centroid
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displacement rates (indicative of pseudopod activity levels), while those of ctsB-GFP
transfectants were significantly (P < 0.05) higher (Fig. 4.4, C). CA074 mitigated the
difference in pseudopod activity between these two populations. These data further support
the ability of ctsB to enhance pseudopod activity.

Figure 4.4. The influence of cathepsin B on dHL60-NC pseudopod activity.
(A-B) Representative images of migrating dHL60s that were transiently transfected through
electroporation with a ctsB-GFP expression vector (ctsB+) or an empty vector (EV) and
maintained under no-flow conditions. (C) DHL60 migration was quantified as mean centroid
displacement rate (MCDR) over a 15 second time interval and plotted as mean ± SD, based on
cell tracings manually performed using ImageJ software. DHL60s transfectants (ctsB+ or EV)
were treated with or without ctsB-specific inhibitor CA074 (5 µM). n = 3 replicates in each
group. *P < 0.05 compared to control. #P < 0.05 compared to CA074.

4.2.3 Fluid shear stress-induced human neutrophil detachment from substrates involves
cathepsin B release
This experiment employed a flow-based cell detachment assay to evaluate the role
of FSS in regulating Mac1-dependent neutrophil adhesivity. Untreated human neutrophils
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pre-adhered to platelet monolayers exhibited time-dependent cell detachment over a 10
min period of FSS exposure (Fig. 4.5, A – B). When human neutrophils were exposed to
FSS in the presence of fMLP (above threshold levels known to block neutrophil shear
responses [20,112]), little detachment from platelet monolayers was observed (Fig. 4.5, C).
Blocking ctsB activity with either E64 or CA074-me also caused human neutrophils to
largely remain adherent to platelet monolayers under FSS. In contrast, neutrophils
pretreated with irreversible serine protease inhibitor, AP (negative control), detached from
platelet layers under FSS exposure in a fashion similar to that of untreated cells.
Similarly, while untreated human neutrophils adhered to HUVEC monolayers
exhibited time-dependent cell detachment upon acute exposure to FSS for 10 min, both
fMLP (above threshold levels that impair the neutrophil shear responsiveness) and ctsB
inhibitors, E64 or CA074-me, blocked this detachment response to FSS (Fig. 4.5, D). On
the other hand, pretreatment of cells with AP had no effect on FSS-induced neutrophil
detachment. These results implicated the ctsB activity in the FSS-induced regulation of
neutrophil adhesion to substrates.

4.2.4 Summary of findings/interpretations
The results of the present study provided evidence for the following significant findings.
•

CtsB enhances neutrophil migration rates under no-flow conditions, likely through the
cleavage of Mac1 integrins during the uropod retraction phase of neutrophil migration.

•

FSS-induced ctsB release serves to restrict neutrophil adhesion to biological substrates
through the cleavage of Mac1 integrins under flow conditions.
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•

Agonist stimulation overrides FSS-induced Mac1 cleavage by promoting neutrophil
adhesion under flow conditions, consistent with its role in the recruitment of
neutrophils during the acute inflammatory response to infection or tissue damage.

Figure 4.5. The involvement of cathepsin B in the fluid shear stress-induced detachment
of neutrophils.
(A-B) Representative images depicting shear-induced neutrophil detachment from platelet (A)
or HUVEC (B) monolayers in response to 5 dyn/cm2 shear stress exposure over a 10 minute
period. Neutrophils were treated with or without ctsB-specific inhibitor CA074-me (50 µM)
and serine inhibitor aprotinin (AP; 5 µM). (C-D) The number of neutrophils remaining
adherent to platelet (C) or HUVEC (D) monolayers after 10 minutes of shear exposure was
normalized to the initial number of adherent neutrophils prior to shear exposure and plotted as
mean ± SD, based on counts manually performed using ImageJ software. Neutrophils were
left untreated or pretreated for 5 minutes with inflammatory agonist fMLP (1 µM), serine
inhibitor aprotinin (AP; 5 µM), ctsB-specific inhibitor CA074-me (50 µM), or cysteine
inhibitor E64 (30 µM). n = 4 replicates in each group. *P < 0.05 compared to control; #P <
0.05 compared to AP. Scale bars are 100 µm.

53

CHAPTER 5: DETERMINING THE EFFECTS OF EXTRACELLULAR
CHOLESTEROL ELEVATIONS ON THE FLUID SHEAR STRESS CONTROL
OF MAC1-DEPENDENT NEUTROPHIL ADHESION
Cholesterol is a structural component of lipid bilayers that modulates the membrane
fluidity of a cell. As the cell membrane becomes enriched in cholesterol, the membrane
becomes more rigid, decreasing its overall fluidity. This has implications for cell
functionalities, such as actin polymerization, adhesion, and migration [125,126]. In the
event that blood cholesterol rises to pathologic levels, such as during hypercholesterolemia,
it is possible that the membranes of blood cells become enriched with cholesterol, which
can impair their functions and contribute to microvascular dysfunction [127,128].
Previously, our lab demonstrated that membrane cholesterol enrichment blocks the
pseudopod retraction response of neutrophils to FSS, likely through an impact on the
membrane fluidity of the cell [27]. Furthermore, we observed that cholesterol-related
blockade of pseudopod retraction was linked to dysregulated tissue blood flow, observed
as impaired tissue blood flow autoregulation in response to poRH [26]. This implicated
impaired neutrophil FSS mechanosensitivity as an early forecaster of microvascular
dysfunction. However, it was unclear how a deficit in neutrophil FSS sensitivity, indexed
by the ability of fluid flow stimulation to restrict neutrophil activity, contributes to the
progression of microvascular dysfunction involving changes in hemodynamic resistance.
Reports in the literature [21], as well as the present dissertation thesis, indicate that
the adhesivity of neutrophils appears to be minimized due to FSS regulation. This suggests
that a deficit in neutrophil FSS sensitivity may contribute to dysregulated adhesion by
impairing this mechanoregulatory control mechanism which involves ctsB-related Mac1
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cleavage. Notably, dysregulated leukocyte adhesion in the microcirculation is also a feature
of hypercholesterolemic pathobiology associated with microvascular dysfunction [77].
Combined, these support the possibility that an impaired FSS mechanosensitivity due to
hypercholesterolemia manifests as dysregulation of not only neutrophil pseudopod activity,
but also cell adhesion.
The study described in this chapter focused on revealing new mechanistic insight
regarding an impairment in the control of neutrophil adhesion by FSS as a putative link
between the pathogenesis of hypercholesterolemia, dysregulated neutrophil adhesion in the
microcirculation, and microvascular dysfunction. Specifically, we examined the possibility
that excess cholesterol in the local environment of the neutrophils due to pathological blood
cholesterol elevations attenuates their FSS-induced Mac1 cleavage response, which
dysregulates neutrophil adhesion and leads to microvascular dysfunction. For this purpose,
we conducted a series of ex vivo human blood studies to explore how cholesterol-related
changes to the membrane fluidity of neutrophils could block FSS regulation of Mac1
surface expression and neutrophil adhesion under flow. The present study also used a
hypercholesterolemic murine animal model to confirm that pathological blood cholesterol
elevations in the in vivo setting promotes dysregulation of neutrophil adhesion by FSS and
that this dysregulation is potentially related to the onset of dysregulated tissue blood flow
indicative of a deficit in the control of the microcirculatory function.
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5.1 Methods
5.1.1 Cells
Human subject recruitment, informed consent, and phlebotomy were approved by
the University of Kentucky Institutional Review Board. Blood was harvested from
asymptomatic volunteers into K2-EDTA-coated vacutainers (Becton-Dickinson) through
the use of standard venipuncture, as previously reported. Human neutrophils were purified
from the whole blood samples as described in section 3.1.1a and suspended in HBSS
containing calcium and magnesium. Parallel to neutrophil isolation, platelets were also
extracted from plasma as reported in section 4.1.1a.

5.1.2 Human neutrophil experimental treatments
To enhance membrane cholesterol content, human neutrophils suspended in HBSS
were treated with 0 – 10 µg/mL cholesterol:MβCD complexes for 15 minutes. After
treatment, neutrophils were washed in PBS and resuspended in HBSS to remove excess
cholesterol conjugates from the cell suspension. For some experiments, human neutrophils
treated with 2 µg/mL cholesterol:MβCD conjugates were subsequently exposed to 0 – 7
mM benzyl alcohol (BnOH) or 0 – 12 mM ethanol (EtOH) for 10 minutes to reverse the
effects of cholesterol enrichment.

5.1.3 Cone-and-plate shear exposure
Human neutrophils in HBSS were exposed to a constant (5 dyn/cm2) laminar FSS
field for 10 min using a custom cone-plate device as described in section 3.1.2.
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Experiments were also conducted with cell suspensions enriched with cholesterol:MβCD
complexes and treated with or without BnOH or ethanol as described in section 5.1.2.
Controls were parallel cell populations maintained under static (no-FSS), but otherwise
similar experimental, conditions.

5.1.4 Immunofluorescence
Immediately after cone-and-plate shear exposure, cells were fixed (1% pformaldehyde in phosphate buffer) and labeled with fluorescent antibodies in 1% BSA in
PBS using standard immunocytochemistry described in section 3.1.3. For human
neutrophils, FITC-conjugated mouse monoclonal antibody (mAb) to CD18 (clones 6.7) or
Alexa Fluor 488-conjugated mouse mAb to CD11b (clone ICRF44) was used to assess
surface expression of adhesion integrins. Rabbit polyclonal (pAb) against ctsB (clone Ab3) and Alexa Fluor 488-conjugated goat pAb (Invitrogen) were also used to assess total
ctsB expression by permeabilized cells, respectively, as described in section 3.1.3.

5.1.5 Neutrophil detachment assay
Autologous human platelets were deposited on sterile glass slides cleaned with
NaOH and allowed to spread into a uniform coating for 30 min as described in section
4.1.3. To create a flow channel for experimentation, the platelet-coated slides were
interfaced with a polycarbonate base with both inlet and outlet ports, as described in section
4.1.3. A pre-cut gasket separating the glass slide and the polycarbonate base formed a 200µm high parallel plate flow channel.
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For flow studies, neutrophils (5x106/mL) were pretreated for 15 minutes with 2
µg/mL cholesterol:MβCD complexes. After PBS washing to remove excess complexes,
neutrophils were treated for 10 minutes with or without 1 – 2 mM BnOH or 7 – 8 mM
ethanol. Controls were neutrophils that were left untreated. Cells were then deposited on
the platelet monolayers for 10 min, at which time non-adherent cells were rinsed away. A
syringe pump was used to impose a FSS of 5 dyn/cm2 on the wall of the channel by
perfusing HBSS through the chamber, as described in section 4.1.3. Bright field
micrographs (100X magnification) of the neutrophils were acquired every 5 s over a 10
min period, and neutrophil detachment was estimated by normalizing the number of
neutrophils visible in each image against that present 30 seconds after flow initiation. This
initial time point was defined to be t = 0 to ensure non-adherent cells were rinsed away
prior to analyses.

5.1.6 Animal studies
5.1.6a Mice
All handling procedures were approved by the University of Kentucky Institutional
Animal Care and Use Committees. Male low-density lipoprotein receptor-deficient
(LDLR-/–) mice were purchased from the Jackson Laboratory and acclimated for 1 week
prior to use. Starting from 8 weeks of age, mice were fed a high fat diet (HFD) enriched in
saturated fat (21% wt/wt fat and 0.15% wt/wt cholesterol; Harland Teklad) for up to 8
weeks to induce hypercholesterolemia. Controls were aged-matched LDLR-/- mice fed a
normal diet (ND; regular chow) for the same duration.
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5.1.6b Diffuse correlation spectroscopy
The blood flow recovery responses of mice were measured in real-time using NearInfrared (NIR) Diffuse Correlation Spectroscopy (DCS), a technique developed by our
collaborator, Dr. Guoqiang Yu (University of Kentucky) [129,130]. DCS works by directly
measuring the motion of RBCs to calculate the rate of blood flow. This technique utilizes
a probe that contains a light source and a detector separated by 6 mm to enable detection
of relative change of blood flow (rBF) within the muscle tissue [131]. The detector picks
up the photons emitted from the light source and, depending on the degree of photon
fluctuations, converts the signals into real-time rBF measurements. During blood flow, the
RBCs are primarily responsible for the photon fluctuations that are detected. DCS has the
advantage of being able to non-invasively measure rBF through deep tissue. The data on
rBF for our experiments was displayed in real-time on a computer monitor to evaluate the
responses of mice to blood flow occlusion (Fig. 5.1, A).
Prior to experimentation, mice were anesthetized by inhalation of 1% isoflurane
(Butler Schein) and the hair on the right hindlimb of each mouse was shaved from the skin.
A makeshift noose was fashioned from PVC tubing (0.05’’ outer diameter) and loosely
wrapped around the proximal end of the right hindlimb so as to not restrict blood flow.
Distal to the PVC noose, a foam pad equipped with a DCS probe was super-glued to the
right hindlimb (Fig. 5.1, B). DCS measurement of rBF was recorded for 5 minutes to
establish a baseline reading. Once the baseline was determined, the PVC noose was
tightened until the real-time DCS measurement of rBF was reduced to zero. Data was
collected for 5 minutes during occlusion, at which point the PVC noose was released using
a high temperature surgical cautery pen to sever the knot and instantaneously reintroduce

59

flow to the target tissue of interest. Data continued to be collected until rBF had recovered
to baseline levels. During the procedure, the body temperature of each mouse was
maintained at 37°C for the duration of the experiment by using a heating pad. After rBF
data had been collected, the mice were euthanized by thoracotomy and exsanguination.
Blood was harvested from mice (~750 µL) for use in cone-and-plate shear experiments. A
small aliquot of blood (~250 µL) was also set aside for cholesterol measurements.

Figure 5.1. Animal study experimental set-up.
(A) Figure depicting the experimental set-up used for murine analyses. The DCS
instrumentation is shown to the right, and the heating pad with mouse is shown to the left. (B)
Figure depicting the mouse on the heating pad. Tape was used to ensure the mouse remained
stationary. The nose of the mouse was placed in a tube delivering 1% isoflurane, visible at the
top of the image. The DCS probe is seen attached to the right hindlimb of the mouse.

5.1.6c Analysis of DCS rBF measurements
MATLAB was used to analyze rBF data from LDLR-/- mice (Fig. 5.2). We plotted
rBF against time in order to identify the highest rate of blood flow. This peak blood flow
was defined to be the greatest rBF value attained after the end of occlusion. In order to
reduce the variability due to noise, all rBF values within 10% of the peak blood flow were
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averaged together and defined as adjusted peak flow (APF). We also calculated the length
of time from cuff release to APF, which was reported as tAPF in our analyses.

Figure 5.2. Representative image of adjusted peak flow analysis.
This plot is used to identify all rBF values within 10% of the peak blood flow. The values are
averaged together and defined as adjusted peak flow (APF). The length of time from cuff release
to APF was also calculated and reported as tAPF in our analyses.

5.1.6d Plasma cholesterol quantification
Plasma was harvested from LDLR-/- mice blood aliquots by centrifugation (1000xg,
5 min) and used to quantify the free, total, and esterified cholesterol levels in the mice. The
concentration of free cholesterol was estimated by using the Free Cholesterol E kit (Wako)
according to the manufacturer’s instructions. Absorbance values were measured at 600 nm
using a BioTek microplate reader (µQuant). The concentration of total cholesterol was
estimated by using the Infinity Cholesterol Reagent (Sigma Aldrich) according to the
manufacturer’s instructions. Absorbance values were measured at 500 nm using the same
BioTek microplate reader. The concentration of esterified cholesterol was estimated from
the free and total cholesterol levels using the established relationship [132]:
𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 = (𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 − 𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜) × 1.67
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5.1.6e Cone-and-plate FSS exposure
Whole mice blood diluted 1:10 (v/v) with HBSS was exposed to a constant (5
dyn/cm2) laminar FSS field for 10 min using a custom cone-plate device as described in
section 3.1.2. Experiments were conducted with no additional treatments. Controls were
parallel cell populations maintained under static (no-FSS), but otherwise similar
experimental, conditions.

5.1.6f Immunofluorescence
Immediately after cone-and-plate shear exposure, cells were fixed (1% pformaldehyde in phosphate buffer) and labeled with fluorescent antibodies in 1% BSA in
PBS using standard immunocytochemistry described in section 3.1.3. For murine
neutrophils, erythrocytes were removed after fixation using RBC lysis buffer (SigmaAldrich) followed by PBS washes. Immunofluorescence was carried out using FITCconjugated rat mAb to CD18 (clone GAME-46), PE-conjugated rat mAb to CD11a (clone
M17/4), or FITC-conjugated rat mAb to CD11b (clone M1/70) to assess surface expression
of adhesion integrins, as described in section 3.1.3.

5.1.7 Flow cytometry
Flow cytometric analyses utilized an LSR II flow cytometer (Becton-Dickinson)
interfaced with Becton-Dickinson FACsDiva software, as previously reported [59].
Neutrophil populations were identified through their FSC, SSC, and CD18 expression as
previously described. The total fluorescence intensities representing the amount of bound
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antibodies were used as measures of antigen specific expression level. By using the total
fluorescence intensities, histograms of antigen-specific fluorescence intensities were
generated for each sample using FCS Express 4 Flow Cytometry software (De Novo
Software). Shear-induced changes in the antigen expression levels were normalized to
those of their respective controls and expressed as “fold change”.

5.1.8 Statistics
Quantitative data derived using human or murine neutrophils were expressed as
mean ± SD for n ≥ 3 replicates. Statistical analyses were performed using JMP (SAS
Institute). One-sample t-tests with P < 0.05 were used to identify significant fold changes
or percent reductions in experimental treatments compared to a reference value.
Comparisons between the means of experimental treatments were performed using
ANOVA and post-hoc Tukey’s test with P < 0.05 indicating significant differences. Linear
regression analysis was also performed using JMP to determine the correlation between
cholesterol, FSS-induced Mac1 cleavage, APF, and tAPF.

5.2 Results
5.2.1 Membrane cholesterol enrichment blocks the shear-induced Mac1 cleavage response
Human neutrophils exposed to 5 dyn/cm2 FSS over a 10 min period exhibited reduced
expression of CD18 and CD11b integrins relative to time-matched, unsheared controls
(Fig. 5.3, A – B). This reduction in integrin expression was dose-dependently blocked for
neutrophils pretreated with cholesterol. Notably, neutrophils treated with cholesterol
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concentrations from 2 – 10 µM did not exhibit significant reductions in CD18 and CD11b
integrins after being exposed to FSS (Fig. 5.3, C – D). These results suggested that
membrane cholesterol enrichment impaired FSS-induced Mac1 cleavage response.

Figure 5.3. Membrane cholesterol enrichment blocks FSS-induced Mac1 cleavage.
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of intact
CD18 (A) and CD11b (B) expressed on the surface of neutrophil suspensions maintained
under no-flow conditions (blue line) or subjected to 5 dyn/cm2 shear stress (red line) using a
cone-and-plate viscometer. A negative (IgG) staining control is also displayed in each plot
(gray shading). Neutrophil suspensions were treated with 0 – 10 µg/mL cholesterol. (C-D)
Based on florescent antibody binding, mean fluorescent intensities of sheared neutrophils
were normalized to their respective no-flow controls and plotted as fold change ± SEM for
CD18 (C) and CD11b (D) integrins. n = 3 replicates in each group. *P < 0.05 compared to a
normalized control value of 1 (dotted line). #P < 0.05 compared to 5 µg/mL. ^P < 0.05
compared to 10 µg/mL. %P < 0.05 compared to 2 µg/mL.

5.2.2 Membrane fluidizers reverse cholesterol inhibition of Mac1 cleavage
Human neutrophils pretreated with 2 µg/mL cholesterol and exposed to 5 dyn/cm2
FSS expressed similar levels of CD18 and CD11b on their surface relative to time-matched,
unsheared controls (Fig. 5.4, A – B). BnOH, a membrane fluidizer [133], selectively
recovered the ability of FSS exposure to promote a reduction in CD18 and CD11b surface
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levels on neutrophils treated with 2 µg/mL cholesterol. Specifically, cholesterol-enriched
neutrophils treated with 1 – 2 mM BnOH exhibited reduced CD18 and CD11b expression
after FSS exposure, a response similar to that of naïve cells. In contrast, cholesterolenriched neutrophils treated with 0 – 0.5 mM and 5 – 7 mM BnOH did not exhibit
reductions in CD18 and CD11b expression after FSS exposure (Fig. 5.4, C – D). These
data provided evidence that the blockade of FSS-induced Mac1 cleavage depends on the
membrane fluidity of the cells. Furthermore, there appears to be an optimal membrane
fluidity that is conducive for an intact Mac1 cleavage response of neutrophils to FSS.

Figure 5.4. Benzyl alcohol reverses the effects of membrane cholesterol enrichment.
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of intact
CD18 (A) and CD11b (B) expressed on the surface of cholesterol-enriched neutrophil
suspensions maintained under no-flow conditions (blue line) or subjected to 5 dyn/cm2 shear
stress (red line) using a cone-and-plate viscometer. A negative (IgG) staining control is also
displayed in each plot (gray shading). Neutrophil suspensions were treated with 0 – 7 mM
BnOH. (C-D) Based on florescent antibody binding, mean fluorescent intensities of sheared
neutrophils were normalized to their respective no-flow controls and plotted as fold change ±
SEM for CD18 (C) and CD11b (D) integrins. n = 3 replicates in each group. *P < 0.05
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 1 mM. ^P <
0.05 compared to 2 mM. %P < 0.05 compared to no chol.
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Similarly to BnOH, EtOH, another membrane fluidizing reagent [134], was shown
to selectively reverse the blocking effects of membrane cholesterol enrichment on FSSinduced Mac1 cleavage (Fig. 5.5, A – B). Briefly, treatment of cholesterol-enriched
neutrophils with 7 – 8 mM EtOH resulted in reduced surface expression of intact CD18
and CD11b integrin subunits on neutrophils after exposure to FSS, similar to that of naïve
cells. In contrast, treatment of cholesterol-enriched neutrophils with 0 – 5 mM or 10 – 12
mM EtOH did not exhibit reductions in CD18 and CD11b expression after FSS exposure
(Fig. 5.5, C – D). These data further supported the existence of an optimal membrane
fluidity level permissive for an intact Mac1 cleavage response of neutrophils to shear.

Figure 5.5. Ethanol reverses the effects of membrane cholesterol enrichment.
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of intact
CD18 (A) and CD11b (B) expressed on the surface of cholesterol-enriched neutrophil
suspensions maintained under no-flow conditions (blue line) or subjected to 5 dyn/cm2 shear
stress (red line) using a cone-and-plate viscometer. A negative (IgG) staining control is also
displayed in each plot (gray shading). Neutrophil suspensions were treated with 0 – 12 mM
EtOH. (C-D) Based on florescent antibody binding, mean fluorescent intensities of sheared
neutrophils were normalized to their respective no-flow controls and plotted as fold change ±
SEM for CD18 (C) and CD11b (D) integrins. n = 3 replicates in each group. *P < 0.05
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 7 mM. ^P <
0.05 compared to 8 mM. %P < 0.05 compared to no chol.
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5.2.3 Membrane cholesterol enrichment blocks the shear-induced release of cathepsin B
Human neutrophils exposed to 5 dyn/cm2 FSS over a 10 min period using a coneplate device exhibited reduced cytosolic levels of ctsB relative to time-matched, unsheared
controls (Fig. 5.6, A). This observation suggested that FSS stimulated the release of ctsB
into the extracellular milieu. Pretreatment of neutrophils with cholesterol blocked this FSS
response. Specifically, neutrophils treated with 2 – 10 µg/mL exogenous cholesterol and
either exposed to FSS for 10 min or maintained under static no-flow conditions displayed
similar levels of ctsB. Thus, exogenous cholesterol administration dose-dependently
blocks FSS-induced ctsB release (Fig. 5.6, B).

Figure 5.6. Cholesterol enrichment blocks shear-induced release of cathepsin B.
(A) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB
expressed in neutrophil suspensions maintained under no-flow conditions (blue line) or
subjected to 5 dyn/cm2 shear stress (red line) using a cone-and-plate viscometer. A negative
(IgG) staining control is also displayed in each plot (gray shading). Neutrophil suspensions
were treated with 0 – 10 µg/mL cholesterol. (B) Based on florescent antibody binding, mean
fluorescent intensities of sheared neutrophils were normalized to their respective no-flow
controls and plotted as fold change ± SEM for ctsB. n = 3 replicates in each group. *P < 0.05
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 0 mM.
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5.2.4 Membrane fluidizers reverse the cholesterol-related inhibition of cathepsin B release
Human neutrophils pretreated with 2 µg/mL cholesterol and exposed to 5 dyn/cm2
FSS over a 10 min period exhibited similar expression levels of the protease ctsB relative
to time-matched, unsheared controls (Fig. 5.7, A). BnOH selectively recovered the ability
of FSS exposure to promote a reduction in ctsB expression by neutrophils treated with 2
µg/mL cholesterol. Specifically, treatment of cholesterol-enriched neutrophils with 1 – 2
mM BnOH reduced the expression of ctsB after FSS exposure, a response similar to naïve
neutrophils. In contrast, cholesterol-enriched neutrophils treated with 0 – 0.5 mM and 5 –
7 mM BnOH did not exhibit reduced ctsB expression after FSS exposure (Fig. 5.7, B).

Figure 5.7. Benzyl alcohol recovers the shear-induced release of cathepsin B.
(A) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB
expressed in neutrophil suspensions treated with BnOH and maintained under no-flow
conditions (blue line) or subjected to 5 dyn/cm2 shear stress (red line) using a cone-and-plate
viscometer. A negative (IgG) staining control is also displayed in each plot (gray shading).
Neutrophil suspensions were treated with 0 – 7 mM BnOH. (B) Based on florescent antibody
binding, mean fluorescent intensities of sheared neutrophils treated with BnOH were
normalized to their respective no-flow controls and plotted as fold change ± SEM for ctsB. n
= 3 replicates in each group. *P < 0.05 compared to a normalized control value of 1 (dotted
line). #P < 0.05 compared to no chol. ^P < 0.05 compared to 2 mM.
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Similarly to BnOH, EtOH was also able to selectively reverse the effects of
membrane cholesterol enrichment (Fig. 5.8, A). Treatment of cholesterol-enriched
neutrophils with 7 – 8 mM EtOH reduced the expression of ctsB after FSS exposure, a
response similar to naïve neutrophils. In contrast, cholesterol-enriched neutrophils treated
with 0 – 5 mM and 10 – 12 mM EtOH did not exhibit reductions in ctsB expression after
FSS exposure (Fig. 5.8, B). Because we previously demonstrated ctsB to be involved in
the selective cleavage of Mac1 integrins, these data further support the existence of an
optimal membrane fluidity level permissive for an intact Mac1 cleavage response. Notably,
the BnOH (1 – 2 mM) and EtOH (7 – 8 mM) concentrations which recover ctsB release
also recover Mac1 cleavage, which is in line with the ability of ctsB to cleave Mac1 under
shear exposure.

Figure 5.8. Ethanol recovers the shear-induced release of cathepsin B.
(A) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB
expressed in neutrophil suspensions treated with EtOH and maintained under no-flow
conditions (blue line) or subjected to 5 dyn/cm2 shear stress (red line) using a cone-and-plate
viscometer. A negative (IgG) staining control is also displayed in each plot (gray shading).
Neutrophil suspensions were treated with 0 – 12 mM EtOH. (B) Based on florescent antibody
binding, mean fluorescent intensities of sheared neutrophils treated with EtOH were
normalized to their respective no-flow controls and plotted as fold change ± SEM for ctsB. n
= 3 replicates in each group. *P < 0.05 compared to a normalized control value of 1 (dotted
line). #P < 0.05 compared to 7 mM. ^P < 0.05 compared to 8 mM. %P < 0.05 compared to no
chol.

69

5.2.5 Fluid shear stress-induced regulation of neutrophil adhesion is inhibited by
membrane cholesterol enrichment
This experimental assay, similar to the one described in section 4.1.3, is used as a
measure of neutrophil adhesivity. As previously shown, untreated human neutrophils preadhered to platelet monolayers exhibited time-dependent cell detachment over a 10 min
period of FSS exposure (Fig. 5.9, A). Pretreatment of neutrophils with 2 µg/mL cholesterol
prior to incorporation into our cell detachment assay attenuated the ability of FSS exposure
to promote their detachment from platelet monolayers (Fig. 5.9, B). This blockade was
reversible by treating cells with membrane fluidizers, BnOH or EtOH, at concentrations
that we showed to be capable of recovering FSS-induced Mac1 cleavage and ctsB release
by neutrophils treated with similar concentrations of exogenous cholesterol. Specifically,
neutrophils pretreated with 2 µg/mL cholesterol and subsequently subjected to the flowbased cell detachment assay in the presence of either 2 mM BnOH or 8 mM EtOH exhibited
significant detachment from platelet layers under FSS exposure, a response that was similar
to that of untreated cells.
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Figure 5.9. Fluid shear stress-mediated regulation of neutrophil adhesion is inhibited by
cholesterol enrichment.
(A) Representative images depicting shear-induced neutrophil detachment from platelet
monolayers in response to 5 dyn/cm2 shear stress exposure over a 10 minute period.
Neutrophils were left untreated or pretreated with or without 2 µg/mL cholesterol, 2 mM
BnOH, or 8 mM EtOH. (B) The number of neutrophils remaining adherent to platelet
monolayers after 10 minutes of shear exposure was normalized to the initial number of
adherent neutrophils prior to shear exposure and plotted as mean ± SEM, based on counts
manually performed using ImageJ software. Neutrophils were left untreated or pretreated with
or without 2 µg/mL cholesterol, 2 mM BnOH, or 8 mM EtOH. n = 3 replicates in each group.
*P < 0.05 compared to 2 µg/mL cholesterol. Scale bars are 100 µm.

71

5.2.6 Hypercholesterolemia inhibits fluid shear stress-induced Mac1 cleavage
Table 5.1 lists the free, total, and esterified cholesterol concentrations in the blood
of male LDLR-/- mice fed a ND or HFD for 6 – 8 weeks. We observed increases in
cholesterol levels that were dependent on the diet duration, consistent with the gradual
onset of hypercholesterolemia due to high fat intake. The free and total cholesterol levels
of 8 week HFD mice were significantly elevated compared to 6 week HFD mice. In
addition, the cholesterol levels of LDLR-/- mice fed a HFD were significantly elevated
compared to LDLR-/- mice fed a ND, further confirming the onset of hypercholesterolemia
in HFD mice. The free and total cholesterol levels of 6 week ND mice, in contrast, were
no different than those of 8 week ND mice.
Table 5.1. Cholesterol concentrations in the blood of LDLR-/- mice.
Cholesterol
Type
Free
Total
Esterified

Diet
ND
HFD
ND
HFD
ND
HFD

Cholesterol Concentration (mg/dl)
6 weeks
8 weeks
75.8 ± 8.1
69.8 ± 16.5
304.0 ± 86.1 *
416.6 ± 60.3 *#
225 ± 27.8
211.8 ± 44.8
759.2 ± 78.3 *
829.0 ± 31.8 *#
249.2 ± 33.6
237.1 ± 49.6
760.1 ± 98.5 *
688.6 ± 70.5 *#

*P < 0.05 compared to diet duration-matched LDLR-/- mice fed a normal diet (ND)
#P < 0.05 compared to LDLR-/- mice fed a high fat diet (HFD) for 6 weeks

Murine leukocytes in blood harvested from LDLR-/- mice fed a ND and exposed to 5
dyn/cm2 FSS for 10 min with a cone-plate device exhibited reduced surface expression of
CD18 and CD11b, but not CD11a, integrins relative to time-matched, unsheared controls
(Fig. 5.10, A – B). In contrast, FSS exposure had little effect on the surface expression of
intact CD18, CD11a, and CD11b integrins on leukocytes in the blood of mice fed a HFD
for either 6 weeks or 8 weeks. Leukocytes from the 6 week HFD mice exhibited an
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attenuated FSS-induced Mac1 cleavage response, while leukocytes from the 8 week HFD
mice exhibited a complete inhibition of FSS-induced Mac1 cleavage.

Figure 5.10. Hypercholesterolemia inhibits the fluid shear stress-induced Mac1 cleavage
response.
(A-B) Based on florescent antibody binding to neutrophils from mice fed a diet for 6 weeks
(A) or 8 weeks (B), mean fluorescent intensities of sheared neutrophils were normalized to
their respective no-flow controls and plotted as fold change ± SEM for CD18, CD11a, and
CD11b integrins. n = 8 replicates in each group. *P < 0.05 indicates significant differences
between normal diet (ND) and high fat diet (HFD) mice. #P < 0.05 compared to a normalized
control value of 1 (dotted line).

Linear regression analyses indicated that, independent of diet type and duration,
plasma cholesterol concentrations of LDLR-/- mice were positively correlated with the
FSS-related surface expression of CD18 and CD11b, but not CD11a, integrins on
neutrophils (Fig. 5.11, A – B). As cholesterol (free and total) concentrations increased,
the integrin surface expression (CD18 and CD11b) was elevated on neutrophils exposed
to FSS. This data provided confirmation that FSS-induced Mac1 cleavage is affected by
pathologic cholesterol elevations, related to hypercholesterolemia.
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Figure 5.11. Plasma cholesterol concentration is positively correlated with Mac1
expression under fluid shear stress exposure.
(A-B) The free (A) and total (B) cholesterol concentrations of LDLR-/- mice were plotted
against the surface expression of CD18, CD11a, and CD11b integrins after exposure to FSS.
*P < 0.05 indicates significant correlation between cholesterol concentration and integrin
expression.
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5.2.7 Cholesterol-related impairment of fluid shear stress-induced Mac1 cleavage is
negatively correlated with APF
We used poRH as a measure of evaluating tissue blood flow autoregulation and
microvascular function in hypercholesterolemic animals. The rBF curves plotted in
MATLAB (Fig. 5.12, A-B) for LDLR-/- mice fed a ND or HFD were similar in response
to that of reactive hyperemia reported in humans [129,131]. To evaluate the tissue blood
flow response in our mice, we analyzed the peak blood flow attained immediately after
cuff occlusion had ended. All rBF data within 10% of the peak blood flow was averaged
and reported as APF to reduce noise. Additionally, the duration of time from cuff release
to APF was measured and reported as tAPF.

Figure 5.12. Representative images of rBF from normal diet and high fat diet mice.
(A-B) The ND (A) and HFD (B) rBF curves of LDLR-/- were plotted in MATLAB against
time. By using the adjusted peak flow (APF) and length of time to APF (tAPF), we could
evaluate the reactive hyperemia of these mice.
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On average, the APF of LDLR-/- mice fed a HFD for both the 6 week and 8 week
durations appeared to be reduced in comparison to LDLR-/- mice fed a ND (Fig. 5.13, A).
However, these diet related changes were not associated with significant difference
between ND and HFD mice. Likewise, the tAPF of LDLR-/- mice fed a ND, on average,
appeared to be prolonged in comparison to LDLR-/- mice fed a HFD (Fig. 5.13, B)
suggesting that tissue blood flow autoregulation in hypercholesterolemic mice may have
also been impaired. However, we did not observe a significant difference between ND
and HFD mice after 6 and 8 weeks of diet.

Figure 5.13. The poRH response appears to be disrupted in hypercholesterolemic mice.
(A-B) The poRH response of LDLR-/- mice fed a ND or HFD was evaluated and reported as
APF (A) and tAPF (B). Bars represent average ± SEM for APF and tAPF. n = 4 replicates in
each group. No significant differences were observed between ND and HFD.

To determine if there was a link between blood cholesterol levels and the tissue
blood flow parameters used in the present study, we performed correlation analyses on
APF and tAPF independent of diet type or diet duration. Table 5.2 summarizes the results
of correlation analyses between plasma cholesterol concentration, FSS-related surface
integrin expression, and APF or tAPF. APF was negatively correlated with free and total
cholesterol concentrations, indicating that as plasma free or total cholesterol levels in the
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blood rose, there was an increase in the degree to which APF was attenuated, which is
indicative of an impaired tissue blood flow autoregulation response to poRH.
Additionally, APF was negatively correlated with FSS-related expression of
CD18 and CD11b integrins. This indicated that a high expression of Mac1 integrins on
neutrophils, likely due to an impaired FSS mechanotransduction response, may contribute
to an impaired autoregulation response to poRH in mice. We also observed that tAPF was
positively correlated with cholesterol concentrations (free and total), indicating that mice
with high plasma cholesterol were likely to have a slow poRH response. However, there
was no apparent correlation detected between tAPF and the FSS-related integrin
expression of Mac1 or LFA1.

Table 5.2. Correlation analysis of APF.

APF
tAPF

FSS-Related Integrin Expression
CD18
CD11a
CD11b
-0.610*
-0.201
-0.569*
0.174
-0.188
0.291

Cholesterol Concentration
Free
Total
-0.455*
-0.572*
#
0.472
0.501#

*P < 0.05 indicates significant correlation with APF
#P < 0.05 indicates significant correlation with tAPF

5.2.8 Summary of data findings/interpretations
The results of the present study provided first evidence for the following significant
findings.
•

There exists an optimal membrane fluidity permissive of FSS-induced Mac1 cleavage
(both ctsB release and Mac1 cleavage)
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•

Extracellular cholesterol elevations block the FSS control of Mac1 surface levels and
neutrophil adhesion, likely through effects on membrane fluidity

•

Diet-induced hypercholesterolemia is associated with impairment of FSS-induced
Mac1 cleavage by neutrophils.

•

FSS-induced Mac1 cleavage and plasma free and total cholesterol concentrations are
correlated with disrupted tissue blood flow in LDLR-/- mice, suggesting a link
between cholesterol-related impairment of neutrophil activity and microvascular
dysfunction associated with hypercholesterolemia.
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CHAPTER 6: DISCUSSION
6.1 First Insight into a Putative Role for Fluid Shear Stress-Induced Cathepsin B
Release in the Regulation of Mac1 Surface Expression
6.1.1 Human neutrophil Mac1 expression is regulated by fluid shear stress-induced release
of cathepsin B
When exposed to FSS, neutrophils release ctsB, a cysteine protease, to cleave CD18
integrins [23]. Researchers identified the role of ctsB in FSS mechanotransduction through
the use of protease inhibitors. There are six main classifications of proteases: cysteine,
serine, aspartic, glutamic, threonine, and metalloprotease [135]. Each protease family can
be selectively blocked through the use of different inhibitors that are commercially
available. Using a panel of protease inhibitors, researchers observed that only a broadspectrum cysteine protease inhibitor, E64, could block shear-induced CD18 cleavage. The
cysteine protease ctsB was later identified after CA074Me, a membrane-permeable
inhibitor specific for ctsB [136], was also demonstrated to prevent FSS-induced CD18
cleavage [23]. Later experiments would later implicate the FSS-induced release of ctsB
into the extracellular environment through the use of the non-permeable ctsB inhibitor,
such as CA074 [93].
While the protease involved in CD18 cleavage had been identified, it was unknown
which of the four different CD18 heterodimers, potentially expressed on the neutrophil
surface, was targeted for cleavage. Among the four CD18 integrin subtypes, CD11a/CD18
(or LFA1) and CD11b/CD18 (or Mac1) are expressed in high quantities on neutrophils,
while very little expression of CD11c/CD18 and CD11d/CD18 is reported [137-139]. This,
combined with the important role of LFA1 and Mac1 in neutrophil adhesion and migration
[115,140], made it likely that ctsB targeted either CD11a or CD11b, if not both integrins.
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Previous research in our lab identified that neutrophils selectively cleaved Mac1 integrins
on human neutrophils, leaving LFA1 integrins untargeted [59]. This narrowed our focus to
the CD18 and CD11b subtypes. But, because the aforementioned research used the broadspectrum cysteine protease inhibitor, E64, to determine that Mac1 was selectively cleaved
due to FSS, it was still unclear if ctsB was capable of cleaving CD11b in addition to CD18.
In the present study, it is apparent that ctsB is involved in the selective cleavage of
Mac1 integrins since it can cleave both CD18 and CD11b integrin subunits. CD11a, in
contrast, is not cleaved due to FSS-induced ctsB release. It is interesting to point out that
FSS exposure reduces CD18 expression by 20 – 30%, and decreases intact CD11b surface
levels by up to 50% [59]. This type of proportional relationship would only be possible if
neutrophils express similar levels of LFA1 and Mac1, a claim supported by prior analyses
of total CD18 subtype expression on neutrophils [141]. Furthermore, these proportional
values suggest that during proteolysis of Mac1, CD18 cleavage occurs after CD11b
proteolysis. Since FSS exposure does not downregulate LFA1 expression, it is likely that
CD11a is somehow able to prevent the cleavage of its partner CD18 subunit. Thus, FSS
exposure does not promote cleavage of all the CD18 integrins off the cell surface, only the
Mac1-associated ones. It is also possible that CD11a blocks the access of ctsB to CD18,
thereby enabling LFA1 to remain on the neutrophil surface in the presence of FSS.
At this point, the reason for why Mac1, but not LFA1 is cleaved under FSS is
unknown. One possible explanation may be explained by the specific contributions of
LFA1 and Mac1 in recruiting neutrophils to the microvasculature during acute
inflammation. LFA1 is typically involved in the early rolling and loose capture stages of
neutrophil recruitment to the microvascular wall [58]. In the absence of inflammatory

80

agonist stimulation, LFA1 may remain intact under FSS exposure to enable the neutrophils
to still interact with the microvascular endothelium as part of their immune surveillance
functionality. Since LFA1 forms loose interactions with the microvasculature [58], this
would enable neutrophils to reversibly bind to the vessel wall under FSS exposure but still
not commit down the inflammatory cascade if they are not needed. In contrast, Mac1 may
be cleaved as a key checkpoint to prevent the commitment of neutrophils along the
inflammatory cascade. Since Mac1 supports the firm adherence of neutrophils to the
microvasculature [58], cleavage of this integrin would prevent neutrophil adherence to,
arrest on, and migration along, the vessel wall and, in turn, maintain neutrophils freelyfloating in the bloodstream. Considering that neutrophil binding to the microvasculature
may influence endothelial-mediated vasomotor activity and/or affect the cross-sectional
area to flow, FSS-induced ctsB release and Mac1 cleavage may preserve microvascular
blood flow regulation and reduce apparent viscosity [72,142], thereby minimizing
microvascular flow resistance.
In addition to analyzing Mac1 cleavage, we also focused on the release of ctsB
under shear exposure. The time-dependent release of ctsB in this study agrees with that
reported for CD18 and CD11b cleavage in previous studies [59]. Furthermore, the observed
extracellular release of ctsB in a soluble form is also supported by our prior experiments
[93]. While the possibility that a lysosomal protease, such as ctsB, is capable of cleaving
Mac1 in the extracellular domain is inconsistent with the widespread view that lysosomal
proteases typically function optimally in an acidic pH [143] and not a neutral pH outside
the cell, evidence supports the extracellular actions of ctsB for many cells. For example,
tumor cells and lymphocytes both secrete ctsB, which has been demonstrated to remain
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stable and functional at neutral pH for extended periods of time [144-147]. Therefore, it is
plausible that ctsB remains functional and able to cleave Mac1 integrins upon its release
by neutrophils.
Interestingly, FSS exposure has been shown to increase granular motion in the
neutrophil cytosol, which may increase the likelihood of degranulation [21]. This increased
granular motion may be linked to the ability of FSS to induce actin depolymerization [55],
considering granule exocytosis is dependent on actin remodeling [148,149]. Thus, the FSSinduced increase in granular motion may represent a key aspect of the mechanism that
underlies the ability of FSS to promote ctsB release. It should be emphasized that the FSSinduced degranulation of neutrophils is unlikely to be due to mechanical trauma which
other investigators reported for neutrophils under flow conditions [150]. The FSS levels
used in the present study were well below those used in these earlier studies [150]. Future
studies will be required to link FSS-induced degranulation with the release of ctsB at low
shear magnitudes.

6.1.2 The shear-induced CD18 cleavage response is characteristic of neutrophils
In addition to confirming the selective cleavage of Mac1 by FSS-induced ctsB
release, we also determined whether the ability to regulate Mac1 expression by FSS
exposure was characteristic of neutrophils. We selected HL60 promyelocytes for use in our
experiments. HL60 cells are capable of differentiating into cells that express a variety of
different phenotypes, including neutrophilic [109]. DHL60-NCs approximate human
neutrophils after undergoing morphological changes and upregulating their expression of
FPR [151] and CD18 integrins on their surface [92,109]. In fact, dHL60-NCs have been
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validated as a model for various neutrophil functions, including migration and chemotaxis
[107,109,152]. Furthermore, dHL60-NCs can be utilized in transfection experiments and
are sustainable in culture for up to one week. This is in contrast to human neutrophils,
which are much more difficult to transfect due to their short (i.e., < 24 hour) lifespan once
outside the body [153,154].
The results from our experiments involving dHL60-NCs confirmed that the FSSinduced cleavage of CD18 integrins is phenotypic of neutrophils. The total reduction in
CD18 expression on the dHL60-NC surface is similar to that observed for human
neutrophils exposed to shear [59]. Additionally, FSS-induced CD18 cleavage of dHL60NCs occurs at an extracellular domain on the integrin, much like with human neutrophils.
This was verified due to the similar expression of intracellular CD18 between sheared and
unsheared samples. We also used E64, a protease inhibitor incapable of crossing the cell
membrane [155-157], to confirm that cysteine proteases are released into the extracellular
milieu and cleave CD18 integrins, in line with our human data.
Notably, the specific integrin cleaved under FSS exposure was found to differ
between human neutrophils and dHL60-NCs. While human neutrophils cleave Mac1, we
observed dHL60-NCs to cleave LFA1. Moreover, E64 prevented shear-induced CD18
cleavage, but only partially blocked cleavage of CD11a subunits. This raised the issue of
how shear-induced CD18, but not CD11a, cleavage was blocked in the presence of E64.
We ruled out the possibility that our flow cytometric analyses were detecting the cleavage
of CD18 dimerized to CD11c, as dHL60-NCs had no detectable expression of this subunit.
Instead, it may be possible that different proteases are responsible for cleavage of CD18
and CD11a by dHL60-NCs. Furthermore, since ctsB expression by dHL60-NCs was much
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lower in comparison to primary neutrophils [158], it is possible that dHL60-NCs express
other cysteine proteases capable of cleaving CD18 and CD11a, but not CD11b, integrin
subunits under shear exposure. The variance in granule distribution between human
neutrophils and HL60s may account for the difference in protease expression for these two
cell types [159]. Alternatively, these cell types may also degranulate differently when
exposed to shear.
While we did not identify the protease involved in FSS-induced CD11a cleavage
for dHL60-NCs, we excluded the involvement of cysteine, serine, and aspartyl proteases.
Since we previously observed lymphocytes to exhibit FSS-induced cleavage of CD11a
[59], a common mechanism or protease may link the FSS cleavage responses of
lymphocytes and dHL60-NCs. We also focused on the involvement of MMPs, as MMP-9
was previously implicated in cleavage of CD18 [160]. However, doxycycline, an antibiotic
with broad proteolytic activity against MMP-9 and cysteine proteases, blocked cleavage to
the same degree as E64, suggesting that MMP-9 is not involved. However, additional
studies are needed to fully rule out this possibility.
Despite the difference in integrin cleavage between human neutrophils and dHL60NCs, these two cells share a similar FSS mechanotransduction response, i.e., CD18
cleavage. Importantly, we demonstrated that shear-induced CD18 cleavage may be blocked
in the presence of threshold concentrations of fMLP. Cleavage of the corresponding CD11
subunit, either CD11b for human neutrophils or CD11a for dHL60-NCs, was also affected
by the same threshold concentrations of fMLP. Notably, the threshold (> 1 μM) of fMLP
required to block integrin cleavage was the same as that reported for attenuating the FSSinduced pseudopod retraction response [20].
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Ultimately, our results pointed toward FSS-induced cleavage of CD18 as a
characteristic trait of neutrophil-like cells. We verified that human neutrophils cleave Mac1
through extracellular release of ctsB in response to FSS stimulation. Furthermore, dHL60NCs cleave CD18 integrins in response to FSS exposure, but were found to express very
little ctsB and, instead, cleave CD11a. Despite this discrepancy in the CD18 integrin
cleavage response to FSS, the dHL60-NCs would be a useful transfectable culture model
to study neutrophil FSS mechanotransduction responses. By transfecting dHL60-NCs to
express ctsB, for example, it may be possible to study FSS-induced Mac1 cleavage in these
cells as a model for human neutrophils.
Overall, the observations from the studies discussed in this section suggest that
CD18 cleavage acts in conjunction with pseudopod retraction under non-inflamed
conditions to minimize neutrophil activation when they are not needed. This provided the
foundation for future experiments involving the regulation of neutrophil adhesion and
migration through FSS-induced ctsB release.

6.2 A Role for Fluid Shear Stress-Induced Cathepsin B Release in the Restriction of
Neutrophil Adhesive Functions
6.2.1 The influence of cathepsin B on neutrophil-substrate interactions during migration
under no-flow conditions
Originally, it was anticipated that exogenous ctsB would impair the ability of
neutrophils to migrate by reducing their adhesive interactions with substrates. Rather than
reducing the migration velocity of cells, exogenous ctsB actually enhanced neutrophil
motility under no-flow conditions. This observation was in agreement with previous
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studies [93]. Although this seems counter-intuitive, it is conceivable that ctsB enhances
neutrophil motility by altering Mac1-dependent processes involved in the pseudopod
projection/retraction dynamics during neutrophil migration.
In essence, neutrophil migration depends on cyclical pseudopod projection and
retraction to induce movement in a specific direction [161,162]. The rapid F-actin
polymerization and formation of cytoskeletal networks at the “leading edge” of a
neutrophil enables lamellipodia to extend from the cell. Once projected, the lamellipodia
are filled with cytoplasm to become functioning pseudopods. The presence of adhesive
integrins, including Mac1, on the functioning pseudopods enables the neutrophil to adhere
to biological substrates and pull itself forward. As the cell body moves forward, the F-actin
begins to rapidly depolymerize not long after pseudopod formation, breaking down the
cytoskeletal networks that provide structure to the adherent pseudopod [163]. This, in turn,
causes the eventual retraction of this pseudopod (referred to as the uropod) at the “trailing
edge” of the neutrophil as the cell body continues to advance forward. Ultimately,
neutrophil migration rate is dictated by this cyclical formation of lamellipodia and
subsequent retraction of uropodia.
In regard to our migration experiments, performed under no-flow conditions, it may
be that the addition of exogenous ctsB to migrating neutrophils had an additive effect on
their motile function by cleaving the extracellular domains of Mac1. This, in turn, would
help to detach uropods and, ultimately, accelerate neutrophil migration. Under flow
conditions, it may be possible that exogenous ctsB (i.e., due to FSS-induced ctsB release)
cooperates with other cell motility processes, such as calpain-mediated cleavage of
intracellular CD18 integrins [164] and Mac1 unbinding kinetics to substrate-bound ligands
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[23,26]. This would be in line with the observed increase in pseudopod retraction rates that
occurred in the presence of exogenous ctsB under no-flow conditions. Moreover, inhibiting
ctsB activity did not have a significant effect on baseline pseudopod retraction and
extension rates, further supporting an additive effect of Mac1 cleavage on cell motility.
While we observed large increases in pseudopod retraction rates, we also observed
small increases in pseudopod extension rates. It is likely that small increases in pseudopod
extension rates for ctsB-stimulated neutrophils were a secondary effect of the large
increases in retraction rates. CtsB-enhanced pseudopod retraction, which involves
accelerated actin depolymerization, likely promoted an increase in the amount of G-actin
monomers in the cytosol. Such an increase in G-actin availability would facilitate the
formation of cytoskeletal structures to support new pseudopod projection. However, this
scenario is speculative and remains to be confirmed.
It is interesting to note that, while ctsB enhanced pseudopod disengagement
through Mac1 cleavage, FSS appears necessary to prevent the formation of new
pseudopods on neutrophils. While we observed ctsB to enhance pseudopod retraction, the
cells still were able to form new pseudopods. However, under flow conditions, only
pseudopod retraction is observed during FSS-induced ctsB release; the cells don’t form
new pseudopods. This may be due to the contributions of FPR, which is reported to be a
neutrophil mechanosensor involved in regulating Rac1 signaling associated with actin
dynamics [108].
Briefly, Rac1, a small guanine triphosphase (GTPase) belonging to the Ras protein
superfamily [165], initiates cytoskeletal reorganization, actin polymerization, and
membrane protrusion when activated [166]. Under FSS exposure in neutrophils, Rac1

87

activity is significantly decreased, in line with a reduction in pseudopod formation [108].
Notably, FPR expression is necessary for neutrophils to form new pseudopod projections
[92]. When neutrophils are exposed to FSS, the expression of FPR on the membrane
surface is downregulated through receptor internalization [63]. Since constitutive FPR
expression is necessary for pseudopod formation, FPR internalization likely prevents the
formation of new pseudopods, potentially by reducing Rac1 activity. This suggests that
FSS-induced ctsB release and FSS-induced FPR internalization work in conjunction to
retract pseudopods and prevent their formation under flow conditions.
Finally, although dHL60-NCs naturally express a low level of ctsB, we were able
to overexpress this protease through transfection and show that both pseudopod activity
and neutrophil motility were slightly elevated in the transfected dHL60-NCs in a similar
fashion to primary neutrophils. These observations supported the ability of ctsB to
influence neutrophil pseudopod activity. Overall, the observations from the present study
provided first evidence that release of ctsB is another way by which neutrophils may
modulate their migration rates in line with its ability to cleave surface Mac1 integrins.

6.2.2 Fluid shear stress-induced cathepsin B release can restrict neutrophil adhesion
through Mac1 cleavage
In addition to its effects on neutrophil motility, we also anticipated that ctsB was
involved in directly regulating neutrophil binding/adhesion to biological substrates. Under
physiologic conditions, many mechanisms are in place to ensure neutrophils remain freelyfloating in the circulation. Some of these regulatory mechanisms are tied to endothelial cell
functions. For example, FSS exposure in the physiologic range can induce endothelial cells
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to release NO, an anti-inflammatory signaling molecule which can minimize leukocyte
adhesion to the endothelium [167]. When exposed to FSS, endothelial cells also
downregulate the expression of adhesion molecules that act as receptors for Mac1, further
diminishing the ability of leukocytes to adhere under physiologic conditions [167,168].
Much like the endothelial cells, neutrophils appear to also be capable of regulating
their own adhesive capabilities. Shedding of Mac1, for example, allows neutrophils in
interstitial tissues to detach from extracellular matrix during chemotaxis [169]. Our own
lab took this a step further by investigating the involvement of ctsB in neutrophil adhesion
to other cells, based on its interactions with Mac1. Previously, the FSS-induced release of
ctsB was reported to reduce the binding of neutrophils in suspension to platelets and
fibrinogen, a Mac1 ligand [59]. This implicated FSS-induced ctsB release and Mac1
cleavage as a preventative measure against neutrophil adhesion to other cells in the blood.
Moreover, these findings suggested that ctsB, in addition to regulating the adhesion of
neutrophils in suspension, could also regulate neutrophil adhesion to unstimulated
endothelium in the microvasculature, which expresses Mac1 counter-receptors.
The idea for the ex vivo, flow-based detachment assay used in the present study
came from experiments performed by Moazzam et al [21]. Using intravital microscopy,
they found that leukocytes would sediment to, adhere to, and migrate along the
microvascular endothelium during transient periods of blood stasis imposed by upstream
microvessel occlusion. But when flow was reconstituted, they would detach in a timedependent fashion and be carried away in the circulation. It should be emphasized that the
detachment resembled a mechanobiologically-driven process and not a result of a physical
shearing off of the cells.
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For our studies, we mimicked this scenario using a microfluidics approach. We
studied the ability of FSS exposure to promote the detachment of neutrophils from platelet
monolayers as a way to quantify the ability of mechanical stimulus to restrict adhesion.
Neutrophils bind to platelets primarily through Mac1 integrins, which allowed us to focus
on the role of FSS-induced ctsB release [113]. We also conducted similar studies using
HUVECs as a model endothelial cell line. The use of an unstimulated venous endothelial
cell line allowed us to more closely approximate the in vivo conditions in the
microvasculature.
Whether adhered to platelets or unstimulated endothelium, the outcomes of our ex
vivo/in vitro flow-based analyses confirmed that FSS regulated the adhesive capacity of
neutrophils by promoting their detachment from platelets and from endothelial
monolayers. Based on our observations, FSS-induced release of ctsB likely served to sever
Mac1-dependent neutrophil adhesion. Importantly, FSS was only found to regulate
neutrophil adhesion in the absence of agonist stimulation. When stimulated with fMLP
concentrations above threshold levels that block FSS-induced pseudopod retraction or
CD18 cleavage, the neutrophils remained adherent to substrates even under fluid flow
stimulation. This outcome is consistent with the likelihood that an acute inflammatory
scenario overrides the FSS mechanotransduction response in order to recruit neutrophils
only when they are needed. Taken together, these observations provided evidence that FSSinduced ctsB is a control mechanism that restricts Mac1 dependent adhesion of neutrophils
under physiological (i.e., non-inflamed) conditions.
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6.3 The Importance of an Optimal Membrane Fluidity in a Functioning Fluid Shear
Stress Mechanotransduction Response
6.3.1 An optimal membrane fluidity is permissive of shear-induced Mac1 cleavage
A growing body of evidence, including that presented in this dissertation, indicates
that FSS mechanotransduction regulates neutrophil activity under physiologic conditions
to keep them quiescent and suspended within the circulation. While inflammatory agonist
stimulation is one way the circulation may supersede the neutrophil mechanosensitivity, it
is also possible for neutrophils to become unresponsive to FSS under pathological
conditions. It is this dysregulation that we believe may contribute to chronic activation,
even in the presence of flow. SHRs, for example, are associated with neutrophils that do
not retract pseudopods when exposed to shear stress [25]. This is thought to involve the
dependence of blood pressure in SHRs on plasma levels of glucocorticoids and the
expression of glucocorticoid receptors on the neutrophil membrane [170,171].
Glucocorticoids have been shown to block FSS-induced pseudopod retraction [24].
However, soluble signaling molecules are not the only way to impair cell
mechanosensitivity, as changes to the cell membrane itself have also been observed to do
this [26,27].
Impaired FSS mechanotransduction responses have previously been demonstrated
in our lab for neutrophils in hypercholesterolemic blood [27]. When exposed to shear in a
cone-and-plate viscometer, neutrophils from hypercholesterolemic mice are unresponsive
to FSS with a deficient pseudopod retraction response to FSS. We reported this to be
dependent on the cholesterol-related membrane fluidity of the cell.
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Additionally, we found that the degree of impairment in neutrophil
mechanosensitivity occurred in a time-dependent fashion (as early as 2 weeks after diet
initiation) that tracked with the gradual increases in blood cholesterol levels over the
duration of high fat dieting intended to induce hypercholesterolemia in mice [27]. It is
likely that, as blood cholesterol concentrations increased over the HFD duration, there was
an increased accumulation of cholesterol in the neutrophil membrane. In support of this,
hypercholesterolemia reportedly increases the cholesterol concentration of blood cell
membranes [104,172]. Conceivably, this gradually increased the degree of impairment in
neutrophil mechanosensitivity during the progression of hypercholesterolemia, something
previously reported by our laboratory [27] and observed in the present study.
The cholesterol-related impairment of neutrophil FSS mechanosensitivity may also
be linked to microvascular dysfunction. Another study performed in our lab found that
neutrophils in hypercholesterolemic mice contributed to the dysregulation of tissue blood
flow autoregulation in response to poRH, a measure of microvascular function [26]. This
suggested that cholesterol-enriched neutrophils with impaired FSS mechanosensitivity is
involved

in

the

progression

of

microvascular

dysfunction

associated

with

hypercholesterolemia. However, it was not clear how impaired FSS related pseudopod
retraction would manifest into microvascular dysfunction. Since we previously
demonstrated that pathologic cholesterol elevations impair FSS mechanosensitivity
through an effect on membrane fluidity, it remained possible that membrane cholesterol
enrichment would impair FSS-induced Mac1 cleavage. Blocking Mac1 cleavage would
disrupt the FSS-induced control of neutrophil adhesion, as we showed using our
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detachment assay, potentially contributing to the dysregulated neutrophil adhesion
observed during hypercholesterolemia [29,77,173].
In the present study, we identified a dose-dependent inhibitory effect of exogenous
cholesterol elevations on FSS-induced cleavage of Mac1 integrins. The threshold
concentration of cholesterol that completely blocked this FSS response (> 2 μg/mL) was
consistent with the concentration our laboratory previously reported to impair FSS-induced
pseudopod retraction (> 1 μg/mL) [27]. Notably, FSS-induced Mac1 cleavage is only
partially blocked in cells treated with 1 μg/mL cholesterol. This suggests that, because FSSinduced pseudopod retraction is completely blocked at 1 μg/mL cholesterol, the attenuated
Mac1 cleavage keeps enough adhesion integrins intact which are capable of forming
membrane-substrate interactions to prevent pseudopod retraction.
After we established 2 μg/mL as the threshold concentration of cholesterol required
to impair FSS-induced Mac1 cleavage, we adopted our previously reported strategy
involving the membrane fluidizer, BnOH, to recover cholesterol-related blockade of FSSinduced pseudopod retraction [27]. We also used a second compound known to fluidize
cell membranes, EtOH. Notably, these membrane fluidizers recovered FSS-induced Mac1
cleavage at concentrations of 1 – 2 mM for BnOH and 7 – 8 mM for EtOH. Importantly,
the ability of 1 – 2 mM BnOH to recover FSS-induced Mac1 cleavage was in agreement
with that observed previously (1 mM BnOH) to recover FSS-induced pseudopod retraction
by neutrophils treated with 2 µg/mL cholesterol [27]. Despite the difference in fluidizer
concentrations, the ability of BnOH and EtOH to reverse the cholesterol blockade of FSSinduced Mac1 cleavage provided further evidence supporting the existence of an optimal
membrane fluidity level permissive for intact neutrophil FSS sensitivity.
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While we had linked changes in neutrophil membrane fluidity to the impairment of
FSS-induced Mac1 cleavage, the exact mechanistic relationship remains to be elucidated.
One possibility is that enriching neutrophil membranes with cholesterol impairs ctsB
release. Membrane stiffening has been reported to prevent the release of pro-inflammatory
cytokines into the extracellular milieu [106]. Thus, it is plausible that FSS-induced ctsB
release is blocked by cholesterol-related changes to membrane fluidity. Our experiments
confirmed that FSS-induced ctsB release was blocked at threshold cholesterol
concentrations corresponding to those determined in Mac1 cleavage experiments.
Importantly, it was possible to reverse the effects of cholesterol impairment by using BnOH
and EtOH to recover FSS-induced ctsB release at the same membrane fluidizer
concentrations (1 – 2 mM BnOH and 7 – 8 mM EtOH) used to reverse the blockade of
FSS-induced Mac1 cleavage by cholesterol.

6.3.2 Cholesterol-related changes in membrane fluidity block fluid shear stress-mediated
restriction of neutrophil adhesion
Our next set of experiments focused on the physiologic implications of this
impaired mechanotransduction response. In particular, we wanted to determine if
cholesterol-related impairment of FSS-induced ctsB release and Mac1 cleavage impairs
the ability of FSS to restrict neutrophil adhesion. Using our flow-based detachment assay
with platelets as a biological substrate, we demonstrated that neutrophils enriched with
cholesterol became unresponsive to FSS exposure and remained adherent to platelet
monolayers despite being exposed to flow. These observations are in line with the reported
ability of cholesterol to enhance neutrophil tethering and firm arrest to activated
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endothelium [126], suggesting that cholesterol may, in fact, block the FSS-induced
regulation of cell adhesion.
Notably, it was possible to reverse the cholesterol-related impairment of FSSinduced neutrophil detachment from platelet layers using either BnOH or EtOH. More
importantly, the concentrations of BnOH and EtOH that recovered FSS-induced
detachment by cholesterol-treated neutrophils were the same as those required to recover
FSS-induced Mac1 cleavage in similarly-treated cells. These observations, combined with
previous results from our laboratory, provided evidence that cholesterol-related changes in
membrane fluidity impair FSS-induced ctsB release and Mac1 cleavage, leading to
dysregulated neutrophil adhesion under flow. Considering that elevated neutrophil
adhesion and activity have been linked with hypercholesterolemia and other downstream
cardiovascular pathologies [29,80,174,175], the results presented in this chapter implicated
cholesterol-related impairment of FSS-induced Mac1 cleavage as a contributing factor.

6.4 The Contributions of Hypercholesterolemia-Related Impairment of Fluid Shear
Stress Mechanotransduction in the Development of Microvascular Dysfunction
6.4.1 Pathologic cholesterol elevations associated with hypercholesterolemia impair fluid
shear stress-induced Mac1 cleavage
In order to verify that impairment of the Mac1 cleavage response to FSS may occur
in the in vivo setting of hypercholesterolemia, we performed studies on neutrophils from
LDLR-/- mice. When LDLR-/- mice are fed a HFD, they gradually develop
hypercholesterolemia as plasma levels of free and total cholesterol increase over the
duration of dieting [176]. We verified this for our study since the LDLR-/- mice on a HFD
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displayed gradual increases in blood cholesterol levels over the 6- and 8-week durations
tested in the present study. Previous studies have shown that leukocytes from humans and
animals with pathological blood cholesterol levels have significantly elevated
concentrations of membrane cholesterol, with associated reductions in membrane fluidity
[172,177]. Overall, this suggests that feeding LDLR-/- mice a HFD was sufficient to: i)
induce a hypercholesterolemic state; ii) enrich the neutrophil membrane with cholesterol;
and iii) reduce the membrane fluidity of neutrophils.
Neutrophils from LDLR-/- mice fed a ND and exposed to FSS were observed to
have an intact Mac1 cleavage response to FSS, similar to that observed for human
neutrophils. However, neutrophils from our HFD mice exposed to FSS exhibited an
impaired Mac1 cleavage response. While 6 weeks of HFD was sufficient to attenuate FSSinduced Mac1 cleavage, 8 weeks of HFD completely blocked shear-induced Mac1
cleavage. Notably, we also observed that the degree to which FSS-induced Mac1 cleavage
was blocked was positively correlated with the plasma cholesterol concentrations (free and
total) of LDLR-/- mice. Therefore, it is likely that a gradual impairment of FSS-induced
Mac1 cleavage follows gradual increases of plasma cholesterol levels.
The current study is not the first to determine that impairment of FSS
mechanotransduction is dependent on the length of time that mice were fed a HFD.
Previous studies have reported similar relationships linking diet duration with an impaired
FSS-induced pseudopod retraction response [27]. In that study, the mice fed a HFD for as
little as 2 weeks exhibited a deficit in their responsiveness to FSS exposure. However, the
fraction of neutrophils that retracted pseudopods gradually decreased as HFD progressed.
After 8 weeks of HFD, neutrophils from hypercholesterolemic mice appeared to extend
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pseudopods in response to shear exposure; i.e., a reverse shear response. These past
observations, combined with the present study, indicate that FSS mechanotransduction is
impaired to a greater degree as membrane cholesterol content increases. Notably, a
significant finding of the present study was demonstrating that hypercholesterolemia also
impairs FSS control of neutrophil adhesion, which has mechanistic implications in
hypercholesterolemia-related pathogenesis.

6.4.2 Cholesterol-related impairment of fluid shear stress-induced Mac1 cleavage is
correlated with dysregulated tissue blood flow in hypercholesterolemic mice
Since we demonstrated that cholesterol can impair FSS-induced Mac1 cleavage,
we also wanted to determine whether pathologic cholesterol elevations associated with
hypercholesterolemia and its detrimental impact on the FSS regulation of Mac1 surface
expression contribute to dysregulated tissue blood flow in LDLR-/- mice. Therefore, we
analyzed the ability of LDLR-/- mice to recover blood flow in hind limbs after 5 minutes of
occlusion, which is similar to poRH in humans [129,131]. The recovery in blood flow was
quantified as the peak flow, reported as APF, immediately after cuff removal. We also
reported the duration of time after cuff removal (i.e., tissue reperfusion) to reach APF,
reported as tAPF.
Hypercholesterolemic mice fed a HFD for 6 and 8 weeks displayed what appeared
to be an impaired poRH response, as APF was decreased and tAPF was increased in
comparison to ND mice. Since poRH can be used as an estimation of microvascular
function and tissue blood flow autoregulation, this suggested that tissue blood flow was
disrupted in hypercholesterolemic mice. However, we did not observe a significant
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different between ND and HFD mice for both APF and tAPF, unlike in previous studies
from our lab [26]. This is likely due to the low statistical power in our analyses, as our
results were based on data from 4 mice in each group, independent of diet type and diet
duration. During earlier studies, the weight of the DCS probe was found to interfere with
the rBF data acquired by DCS during poRH. By placing the probe under the mouse leg,
rather than on top of the leg, we eliminated the source of error for future experiments. In
the future, we would expect at least 7 – 8 mice in each experimental group would be needed
to detect significant differences similar to that previously reported for APF and tAPF [26].
We also performed correlation analyses to determine how plasma cholesterol levels
were linked with the poRH response in mice, independent of diet type and diet duration.
Our correlation analyses found that APF in LDLR-/- mice was negatively correlated with
plasma cholesterol levels and, most importantly, this correlation was significant. Thus,
elevations in cholesterol appear to have an effect of reducing APF. An interpretation of this
outcome may be that pathological cholesterol concentrations associated with
hypercholesterolemia contribute to dysregulated tissue blood flow, which is in agreement
with prior reports for mice and humans [26,80,128]. Additionally, tAPF was positively
correlated with plasma cholesterol levels, indicating that elevations in cholesterol lengthen
the amount of time necessary to achieve a complete poRH response. Since poRH can be
used to estimate tissue blood flow autoregulation, we can interpret this data to say that
blood cholesterol levels are prognostic of an impairment in tissue blood flow
autoregulation. This agrees with numerous reports demonstrating a link between blood
cholesterol levels and the progression of microvascular dysfunction [178,179].
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We also found that APF was negatively correlated with the degree to which FSSinduced Mac1 cleavage was blocked, independent of diet type and duration. These results
point to cholesterol-related impairment of FSS-induced Mac1 cleavage as a potential factor
that contributes to hypercholesterolemia-related reductions in APF. Specifically, FSSinduced regulation of neutrophil adhesion may be compromised by blocking Mac1
cleavage under FSS exposure, potentially resulting in dysregulated neutrophil adhesion
characteristic of the hypercholesterolemic microcirculation [29,77,173]. Notably,
dysregulated neutrophil adhesion has been demonstrated to contribute, in part, to the
progression of microvascular dysfunction [4,50,128,180-182]. Therefore, it is conceivable
that the disrupted tissue blood flow in our studies, which manifested as decreased APF,
resulted from the cholesterol-related impairment of FSS regulatory mechanisms.
Overall, the results from our mice study, combined with those from our human
neutrophil detachment experiments, implicate the cholesterol-related dysregulation of
neutrophil behavior in the progression of microvascular dysfunction associated with the
onset and progression of hypercholesterolemia. This relationship between neutrophil
adhesion, FSS-induced Mac1 cleavage, and dysregulated tissue blood flow may help
design future studies to definitively link an impaired FSS response to the progression of
microvascular dysfunction.
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CHAPTER 7: CONCLUSIONS
In summary, the evidence provided in this study supports the importance of FSS
mechanotransduction in the physiologic control of neutrophil activity. Specifically, this
dissertation provided new evidence that cleavage of Mac1 by FSS-induced ctsB release
serves to regulate neutrophil adhesion to unstimulated endothelium. By downregulating the
expression of Mac1 adhesion integrins, FSS mechanotransduction likely ensures
neutrophils remain quiescent and freely-floating in the circulation. We also provided
evidence for the existence of an optimal membrane fluidity level permissive of an intact
Mac1 cleavage response to flow. Perturbations that alter the membrane fluidity outside this
optimal range are expected to impair the physiological regulation of neutrophil activity by
FSS, thereby contributing to pathology.
Additionally, we report that cholesterol-related changes in membrane fluidity may
lead to impairment of the FSS-related control of neutrophil adhesion by Mac1 cleavage.
This has implications during hypercholesterolemia where blood cholesterol elevations, by
impairing FSS-induced ctsB release and Mac1 cleavage, may promote dysregulated
neutrophil adhesion in the microvasculature and, in doing so, lead to microvascular
dysfunction. Ultimately, these results suggest that dysregulated neutrophil adhesion,
induced by cholesterol-related impairment of FSS mechanotransduction, may be one of the
earliest upstream factors which disrupt tissue blood flow and contribute to microvascular
dysfunction, a precursor to lethal vascular disease due to hypercholesterolemia.
Future studies should focus on further elucidating mechanistic aspects of this
potential link between dysregulated neutrophil adhesion and microvascular dysfunction.
For example, intravital microscopy can be used to monitor neutrophil adhesion to the
endothelium under flow conditions in hypercholesterolemic mice. By using a micropipette
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to first induce blood stasis followed by its removal to reconstitute microvascular flow, it
would be possible to determine whether adherent neutrophils in hypercholesterolemic mice
respond to shear exposure. Additionally, studies in ctsB-deficient mice can be performed
in parallel with those from LDLR-/- mice to determine if a loss of ctsB activity is also linked
to dysregulated neutrophil adhesion and microvascular dysfunction in vivo. This would
suggest that the dysregulated adhesion of cholesterol-enriched neutrophils in
hypercholesterolemic mice may be due to a loss in ctsB activity, likely due to membrane
fluidity-related impairment of ctsB release. Verification of ctsB release from cholesterolenriched neutrophils can then be determined using single-molecule tracking with
fluorescently labeled ctsB. Finally, it is important to understand the early
mechanosignaling events at the mechanosensor and secondary messenger levels to better
understand the mechanobiology of neutrophils under FSS exposure. Overall, these studies
may contribute toward the development of novel therapeutic treatments that target
cholesterol-related pathobiology (e.g., impairment of FSS mechanotransduction in
neutrophils) rather than just targeting blood cholesterol levels, a strategy that is still
controversial in terms of its efficacy.
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APPENDIX A
A.1 Introduction
Peripheral hemodynamic resistance is affected by activated neutrophils, either
through capillary plugging or adhesion to the microvasculature [183,184]. However,
neutrophils flowing through the blood in an inactivated state also influence apparent
viscosity [72,142], which affects flow resistance. We performed in vitro experiments to
test whether activated neutrophils could significantly enhance their impact on
microvascular flow by altering blood rheology. In this regard, we sought in vitro
affirmation that sustained neutrophil activation may impact peripheral resistance and
downstream tissue perfusion, both of which may contribute to microvascular pathobiology.
The following description of this study is derived with minor modifications from
our previously published work:
Akenhead ML, Horrall NM, Rowe D, Sethu P, Shin HY. In Vitro Evaluation of the Link
Between Cell Activation State and Its Rheological Impact on the Microscale Flow of
Neutrophil Suspensions. ASME. J Biomech Eng. 2015;137(9):091003-091003-10.

A.2 Methods
A.2.1 Microfluidics-based microvascular mimics
To evaluate the impact of neutrophil pseudopod activity on flow resistance in
microfluidics mimics of non-capillary (i.e., arteriolar/venular) microvessels, we utilized
two

different

experimental

configurations.

One

configuration

utilized

a

polydimethylsiloxane (PDMS) chamber consisting of a single rectangular cross-section
microchannel (w: 500 µm; h: 50 µm; l: 20 mm). We also simulated a microvascular
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network by utilizing a PDMS chamber with twenty 20x50 µm rectangular channels
arranged in parallel.
Prior to experimentation, neutrophil suspensions (1x106 cells/ml) were stimulated
with 0 or 10 nM fMLP for 5 min and subsequently fixed in 1% p-formaldehyde. The
neutrophil suspensions were perfused through the microfluidic chamber for 3 minutes at
flow rates of 1, 1.5, 2, and 5 mL/min in the absence or presence of autologous erythrocytes
at 10% hematocrit. During perfusion, we measured the infusion pressure (relative to the
atmosphere). For analyses, the baseline pressure reading (Pt=0) (obtained before the onset
of flow) was subtracted from each instantaneous infusion pressure reading (Pt), and used
as the instantaneous pressure gradient ∆P = Pt - Pt=0. To reduce the impact of noise, we
averaged the pressure gradient values recorded over the last 2 min of constant flow (Q) at
each flow rate. These averages were then used to quantify the flow resistance (slope of a
∆P vs. Q curve).

A.3 Results
A.3.1 The rheological impact of neutrophil activation is enhanced by the presence of
erythrocytes in microscale flows
To simulate flow without plugging through the largest microvessels within the
microcirculation, we utilized a single-channel microchamber during experiments. Both
activated and inactivated neutrophil suspensions were observed to have similar perfusion
pressures during flow through this chamber (Fig. A.1, A). We also simulated microscale
flow by utilizing a microvascular network chamber during experiments. Much like the
single channel microchamber, both activated and inactivated neutrophil suspensions were
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observed to have similar perfusion pressures during flow through the microvascular
network chamber (Fig. A.1, B). Based on the pressure vs. flow curves generated for each
chamber (Fig. A.1, C), activated and inactivated cell suspensions were determined to have
a similar impact on flow resistance (Table A.1).

Figure A.1. In the absence of erythrocytes, neutrophil activation does not significantly
impact the flow properties of microvascular mimics.
(A-B) Plots of perfusion pressure versus time for a single 500x50 µm channel (A) or a network
of twenty 20x50µm microchannels (B) were generated at various flow rates (0, 1, 1.5, 2, and 5
mL/hr) for purified neutrophil suspensions maintained in an inactivated state (solid black line)
or activated with 10 nM fMLP (solid red line). (C) To determine effects of neutrophil activation
on microchannel flow resistance, pressure versus flow curves were generated from the raw data.
Pressure values were averaged over the last 2 minutes recorded at each flow rate. From the
generated curves, resistance values corresponding to single channel (inactivated, open triangles;
activated, solid triangle) or microvascular network (inactivated, open circles; activated, solid
circles) were found by computing the slope of each line. Points are mean ± SEM. n = 3.
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Table A.1. Summary of flow resistance during neutrophil perfusion.

Single
Channel
MultiNetwork

Resistance (cmH2O/(mL/hr)
Inactivated
Activated

P-value

18.92 ± 6.26

18.65 ± 5.54

P > 0.05

27.89 ± 3.76

27.9 ± 3.28

P > 0.05

Similar experiments were repeated in the presence of 10% hematocrit to evaluate
the contributions of erythrocytes. The perfusion pressure readings obtained from the flow
of activated neutrophil populations for both the single-channel microchamber (Fig. A.2, A)
and the micronetwork chamber (Fig. A.2, B) appeared to be elevated in comparison to that
of inactivated neutrophil populations. In line with this, activated neutrophils in the presence
of erythrocytes appeared to increase the slope of the pressure flow curves for both chambers
(Fig. A.2, C). Quantitatively, while the baseline resistance to neutrophil perfusion of both
chambers was increased by the addition of 10% hematocrit alone, fMLP stimulation, when
combined with erythrocytes, significantly (P < 0.05) elevated the flow resistance of both
chambers (Table A.2). Notably, the increase in flow resistance of the micronetwork
chamber due to neutrophil activation in the presence of hematocrit was significantly (P <
0.05) higher than that of the single-channel microchamber (Table A.3).
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Figure A.2. Suspensions of activated neutrophils and erythrocytes significantly impact
the flow properties of microvascular mimics.
(A-B) Plots of perfusion pressure versus time for a single 500x50 µm channel (A) or a network
of twenty 20x50µm microchannels (B) were generated at various flow rates (0, 1, 1.5, 2, and 5
mL/hr) for purified neutrophil suspensions maintained in an inactivated state (solid black line)
or activated with 10 nM fMLP (solid red line), and subsequently supplemented with 10%
hematocrit. (C) To determine effects of neutrophil activation on microchannel flow resistance,
pressure versus flow curves were generated from the raw data. Pressure values were averaged
over the last 2 minutes recorded at each flow rate. From the generated curves, resistance values
corresponding to single channel (inactivated, open triangles; activated, solid triangle) or
microvascular network (inactivated, open circles; activated, solid circles) were found by
computing the slope of each line. Points are mean ± SEM. n = 3.

Table A.2. Summary of flow resistance during neutrophil and erythrocyte perfusion.

Single
Channel
MultiNetwork

Resistance (cmH2O/(mL/hr)
Inactivated
Activated

P-value

21.91 ± 6.87

22.7 ± 7.41

P < 0.05

31.98 ± 2.21

34.91 ± 3.44

P < 0.05

106

Table A.3. The contributions of erythrocytes in elevating flow resistance.
Percent Difference
0% Hct
10% Hct
Single
Channel
MultiNetwork

1.4%

3.61%*

0.035%

9.16%*#

*P < 0.05 compared to 0% difference (one-sample t-test)
#P < 0.05 compared to percent difference in single channel (Student’s t test)

A.3.2 Summary of findings/interpretations
The results of the present study provided evidence for the following significant findings.
•

Neutrophil activation in blood-like cell suspensions enhances the flow resistance of
microscale channels of sizes representative of those found for non-capillary
microvasculature.

•

Hematocrit is an important contributor to the effects of neutrophil activation on the
flow resistance of microchannels.
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